Latest revision as of 11:01, 4 December 2016

Welcome to iGEM Aachen 2016

Lab Book

To express a photocaged protease, in our case subtilisin E, we developed three lab strategies. Their milestones can be seen below in three different timelines, one for every sub-division. Details about reaching these milestones will become visible, if you click on the corresponding circles. On the page Project Idea the theory beneath our lab work is described and on the subpage Protocols & Methods the exact protocols can be seen, if you would like to repeat the experiments. It can also be helpful to have a look at our primers list.

Photocaging - Targeting Serine in Saccharomyces cerevisiae

Expression of Subtilisin E

As the first step to reach our aim of producing an inactive photocaged subtilisin E variant, which can be activated by light, we researched on the recombinant expression of subtilisin E in S. cerevisiae . The native subtilisin E is a gene of Bacillus subtilis which we could receive from the institute. In the following steps our procedures can be traced.

Determination of Parameters

Strain Selection

S. cervisiae
* the synthetase is made for this strain
* needs to have the deficiencies of both chosen vectors

Characterization of Strand [1]

Name	Auxotrophies	Prototrophies	Mating Type
CENPK2-1D	his3D1; leu2-3_112; ura3-52; trp1-289	MAL2-8c; SUC2	MATalpha

Growth – Temperature
We tested the growth in different temperatures for optimization:

Temperature	OD at start	OD after 24 h
25°C	0	0
30°C	0	>2
37°C	0	0

The S. cerevisiae strand only grew at 30°C.

Growth – Media
As our CENPK2-1D strand was growing poorly in the SC-U medium, we got the advice to try the same medium but with a higher amount of amino acids (SD-U).

Medium	OD at start	OD after 24 h
SC-U	0.1	2.9
SD-U	0.1	9.1

After OD measurements it was obvious, that the SD-U medium gave the CENPK2-1D better conditions for growth

Growth – Protection against Contamination
To prevent bacterial contaminations, we made a comparison of the growth of our used strand in medium with and without ampicillin.

Medium	OD at start	OD after 24 h
YPD	0	2.7
YPD+Amp	0	2.6

The growth in both media seems equal. So we decided to only use medium with additional ampicillin in future.

Selection of Vector

Requirements for Vector

1. Secretion
Subtilisin E must be secreted as we do not know if it can be expressed active in cytoplasm. For industry secretion is a big advantage as it allow continuous production

2. Shuttle vector
For amplifying the vector easily it needs to have an ori and selective marker in E. coli

3. Selection system in yeast
different than the selection of synthetase plasmid which is tryptophane auxotrophy
auxotrphy must be different from trytophane

Available Vectors for Us:

Figure 1: pTEF-MF

Figure 2: pYes2

Figure 3: pcfb255 [2]

Vector	pTEF-MF	pYES2	pCFB255 [2]	pYES2Mfalpha	pCFB255MfalphaTEF1	pESC-Trp
selection in S. cerevisiae	ura3	ura3	ura3	ura3	ura3	trp
selection in E. coli	Amp	Amp	Amp	Amp	Amp	Amp
Secretion	yes	no	no	yes	yes	no
Genome Integration	no	no	yes	no	yes	no
Length	6.6 kb	5.9 kb	-	6.2 kb	-	6.5 kb
Promoter	TEF1	GAL	TEF1	GAL	TEF1	GAL

References

[1]http://www.euroscarf.de/plasmid_details.php?accno=30000B [2]Jensen et al. (2013). “EasyClone: method for iterative chromosomal integration of multiple genes in Saccharomyces cerevisiae” FEMS Yeast Research 14(2): 238-248. Provided by Irina Borodina, Technical University of Denmark

Cloning

Cloning of Subtilisin E Gene from Bacillus subtilis into an E. coli - S. cerevisiae Shuttle Vector

In the beginning we received the PHY300PKL plasmid with the subtilisin E gene. We chose an uracil deficient Saccharomyces cerevisiae strand and a shuttle vector carrying the URA gene. The vector has the secretion tag MF alpha to make harvesting of produced protein more convenient. After cloning the subtilisin E gene into the vector in Escherichia coli we want to transform it in S. cerevisiae and make a test expression. A scheme of the cloning can be seen below:

Figure 1: Scheme of cloning the Bacillus gene for subtilisin E into pTEF-MF

For the detailed labbook entries see this PDF.

Cloning of Codon Optimized Subtilisin E in pTEF-MF
As the test expression of the Subtilisin E gene from bacillus subtilis was not successful we used a codon optimized variant of the gene we had on the PHY300PKL plasmid. As a host we chose the S. cerevisiae strand CENPK2-1D again as it has the deficiencies we need for selection. As a vector backbone we tried the pTEF-MF vector again. A scheme of the cloning can be seen below:

Figure 1: scheme of cloning the codon optimized gene for subtilisin E into pTEF-MF

For the detailed labbook entries see this PDF.

Cloning into the inducible vector pYes2
After day 10 of cloning the codon optimized subtilisin E into pTEF-MF we tried a parallel strategy in the PYES2 vector. A scheme of the cloning can be seen below:

Figure 1: scheme of cloning the codon optimized gene for subtilisin E with MFalpha into pYES2

For the detailed labbook entries see this PDF.

Genome Integration (pCFB255) [1]

After codon optimization we planned to have the subtilisin E inside an integrative vector pCFB255 [1] for better expression in Saccharomyces cerevisiae
For the detailed labbook entries see this PDF.

References

[1]Jensen et al. (2013). “EasyClone: method for iterative chromosomal integration of multiple genes in Saccharomyces cerevisiae” FEMS Yeast Research 14(2): 238-248. Provided by Irina Borodina, Technical University of Denmark

Test Expression

Introduction
After cloning the subtilisin E into the vectors pTEF-MF, pyes2 and the genome integration vector pCfB255 [1] a test expression was made. We used the following methods to test for proteolytic activity:

Skim Milk Assay
The skim milk assay is a non specific test for proteolytic activity. Lysis of casein leads to a clear solution while the solution remains white when the proteolytic activity is missing.

AAPF Assay
The AAPF assay is a very specific test for proteolytic activity in serine proteases.

TCA Precipitation
It is used to precipitate proteins from cell culture supernatant to gain a higher concentration.

SDS Gel
An SDS gel can be used to make proteins visible. SDS (sodiumdodecyl-sulfate) charges all proteins negative, so that they migrate in an electric field. It is a size based sorting method.

Results in pTEF-MF
In the pTEF-MF the secretion tag MFalpha should lead to a secretion. We tested the supernatant of 24 h, 48 h and 72 h cultures with the methods described above but did not get any positive results. We also crushed the cells to test them with the same methods after 24 h, 48 h and 72 h but there was no positive result either. Subtilisin E expression was not possible in this expression system.

Results in pYES2
In the pyes2 vector with additional MFalpha secretion tag Subtilsin E also should be secreted. We tested the vector like pTEF-MF except we induced it first with 20 % Galactose and fed 20 % again after every 24h.

Results in pCFB255[1]
Tests were performed just like the pTEF-MF, but also genome integration did not result in secretion of an active protease.

References
[1]Jensen et al. (2013). “EasyClone: method for iterative chromosomal integration of multiple genes in Saccharomyces cerevisiae” FEMS Yeast Research 14(2): 238-248. Provided by Irina Borodina, Technical University of Denmark.

SDM Ser to UAG

Introduction
To make insertion of the DMNB-serine into the enzyme possible, an amber stop codon has to be at the respective site. In order to achieve this, we made a quikchange of our gene.

For all agarose gels we used 1% agarose and 1 kb Thermo scientific ladder 08:

Day 1

SDM Subtilsin E: Serine ²²¹ to amber codon
We made a SDM (site directed mutagenesis) with YP0010 and YP0011. As template we used 1µl of sequenced subtilisin E in pTEF-MF (day 14 from cloning of subtilisin E gene from Bacillus subtilis) with a concentration of 13,6 ng/µl per 50 µl reaction.

Programm 1 (cycles: 3 D-E)

ID	98°C	30 sec
D	98°C	10 sec
A	65-74°C	45 sec
E	72°C	6 min
S	8°C	storage

Programm 2 (cylces: 15 D-E)

ID	98°C	30 sec
D	98°C	10 sec
A	65-74°C	45 sec
E	72°C	5 min
FE	72°C	10 min
S	8°C	storage

We used colums 4-9

Colum	4	5	6	7	8	9
Temperature	66.4°C	67.4°C	68.6°C	69.8°C	71°C	72.1°C

Agarose Gel
We made an agarose gel to see if our modified subtilsin E was amplified with the primers. The expected size is 7 700 bp.

1: PCR product of column 4
2: PCR-product of column 5
3: PCR-product of column 6
4: PCR-product of column 7
5: PCR-product of column 8
6: PCR-product of column 9
0: ladder

There are clear bands at all the six annealing temperatures, so the PCR worked well.

DpnI Digestion
We did a DpnI digestion overnight of the quik change products.

Day 2

PCR-Clean-Up
We made a PCR-clean-up of the DpnI digested products to prepare them for transformation in E. coli Dh5alpha.

Transformation in DH5alpha
We transformed the purified SDM product into E. coli DH5 alpha and plated them on LB + Amp plates.

Day 3

Transformation Results
The transformation was successful.

Overnight Cultures
We made overnight cultures of 4 of the grown colonies in 5 ml LB + Ampicillin.

Day 4

Plasmid Isolation
We isolated the plasmids of the quikchanged subtilisin E in pTEF-MF overnights.

Nanodrop
We measured the concentration of isolated plasmids via nanodrop:
1.  912.6 ng/µl
2.   910 ng/µl
3.   866 ng/µl
4.   660.4 ng/µl

Sequencing
We sent the four samples of isolated plasmids in for sequencing with YP0007, YP0008 and YP0009.

Day 5

Sequencing Results
All four samples showed the right sequence.

Results

We did not continue after this step as the subtilisin E expression did not work.

Test Expression

As our previous efforts did not produce usable results, we did not reach this point.

Expression of Synthetase

In order to incorporate our DMNB-serine into the protease we aim to produce, we have to provide the organism with an orthogonal tRNA/Synthetase pair specific for this non canonical amino acid. We found that this has been created by the Schultz lab and contacted them. We were grateful that they agreed to send us their plasmid and thus made our work possible in the first place.

Determination of Parameters

Strain selection

S. cervisiae
* Synthetase is made for this strand
* needs to have the deficiencies of both chosen vectors

Name	Auxotrophies	Prototrophies	Mating Type
CENPK2-1D	his3D1; leu2-3_112; ura3-52; trp1-289	MAL2-8c; SUC2	MATalpha

Vector selection

The lab of Peter G. Schultz kindly sent us the plasmid carrying the genes for the tRNA/Synthetase pair (pESCTrpLeuRSBH5T252A) orthogonal in Saccharomyces Cerevisiae and capable of integration the photolabile unnatural amino acid 4,5-Dimethoxy-2-nitrobenzyl-serine.

Check Genes

Introduction

Here we introduced the tRNA/synthetase plasmid into the organism we sought to express subtilisin E in, in order to be able to integrate the noncanonical amino acid into the protease .
For all agarose gels we used 1% agarose and 1kb Thermo scientific ladder 08

Day 1

Transformation
Unfortunately, the tube was open upon receipt and no traces of dried DNA material were visible. Thus it was decided to transfer competent cells directly into the tube during the process of transformation in E. coli DH5alpha.

Day 2

Overnights
We made 5 ml LB + Amp overnight cultures of three different colonies grown on yesterday’s transformation plates.

Day 3

Cryo Cultures and Plasmid Isolation
We prepared cryo cultures with 1 ml of yesterday´s overnights and isolated the plasmids from the remaining culture. Nanodrop
We measured the concentration of the isolated plasmids: 1: 202 ng/µl 2: 214 ng/µl 3: 263 ng/µl
Control Digest
The plasmid was digested with EcoRI and checked on an agarose gel.

1: Colony 1 2: Colony 2 3: Colony 3 0: Ladder

Day 4

Preparation of competent yeast cells
We prepared competent cells out of a Saccharomyces CENPK21D strand

Day 5

Transformation of pESCTrpLeuRSBH5T252A into Saccharomyces Cerevisiae
We transformed pESCTrpLeuRSBH5T252A into an Uracil and Tryptophan deficient Saccharomyces cerevisiae strand (CENPK21D).

Day 8

Transformation Results
The transformation grew but at the control plates where untransformed competent cells where plated on SD-Trp medium also a few colonies grew with no obvious reason.
Overnight Culture
5 ml Overnight cultures of 5 of the cultures derived from the transformations two days ago were made in SD-U medium with ampicillin.

Day 9

Cryo Cultures and Plasmid Isolation
We prepared cryo cultures with 1 ml of yesterday´s overnights and isolated the plasmids from the remaining culture. As an alternate first step the yeast cell walls were lysed with beads by vortexing cultures in buffer with them for 30 minutes instead of the bacterial lysis buffer.
Nanodrop
We measured the concentration of the isolated plasmids:
1: 400 ng/µl 2: 316.7 ng/µl
Agarose Gel
The isolated plasmids were digested with EcoRI and put on a gel.

S = Synthetase plasmid for control 1-4 = Colony 1-4 0 = Ladder
No plasmids were visible. Advice from our advisors who worked with yeast suggested that we transformed the plasmids we isolated into E. coli for amplification and then look at it on a gel again.

Day 10

Transformation
The isolated plasmids the yeast cells were transformed into E. coli DH5alpha.

Day 11

Overnights
Overnights of two colonies from yesterday’s transformation were made.

Day 12

Plasmid Isolation + Cryos
We made cryo cultures from yesterday’s overnights and isolated plasmids from the remaining culture. Nanodrop
The concentration of the isolated plasmids was measured with a nanodrop: 1. 807,8 ng/ul 2. 815,5 ng/ul Digestion
We to cut the samples 2a-4b plus the control vectors with confirmed sequence with EcoRI.
Agarose Gel
Oddly, the agarose gel shows that the plasmids are not at the expected size.

3a, 3b: isolated plasmids 1 + 2 CSyn: Control (synthetase plasmid) (other slots are not relevant for this section)

Sequencing
We sent the original plasmids for sequencing with primers YP0022 and YP0023, that bind to the respective promotors and primers to find out the sequence of the plasmid, as this was not given to us along with the plasmid. We hoped to find out what went wrong in the transformation process into yeast like this. Also we contacted a research group, who worked with this plasmid for sequences of primers, as we could not reach the group we originally obtained it from, and got YP0016b, YP0017b, YP0018b and YP0019b. With these we also sequenced.

Day 13

Results
The sequencing revealed that we did not have the plasmid we expected, as the primers did not bind. Our efforts to receive the right sequence of this plasmids somehow were unsuccessful. As we had no way to control, if what we were working with was the right thing and without mutations, we sadly could not use the synthetase in our work.

Test Expression

As we are still dealing with challenges of the previous step, we did not yet continue to this point.

Co-transformation

As our previous efforts did not produce usable results, we did not reach this point.

Test Expression

As our previous efforts did not produce usable results, we did not reach this point.

Test Photocleavage and Activity

As our previous efforts did not produce usable results, we did not reach this point.

Photocaging - Targeting Tyrosine in Escherichia coli

Expression of subtilisin E in E. coli

Our aim here was to express the natural subtilisin E in E. coli and to determine the optimal conditions.

Building the expression system

Day 1

Our aim was to create a functional expression system for subtilisin E in Escherichia coli. At first, we had to optimize the sequence of the subtilisin E gene from Bacillus subtilis for Escherichia coli codon usage. For this purpose, our DNA sequence was improved with the DNA and protein sequence analysis tool ‘Geneious’ and the ‘Codon Optimization Tool’ from IDT. In the following, we proceeded to design the expression system digitally.

The expression system consists of commonly used BioBricks:

Figure 1: Visualization of the system designed for the expression of subtilisin E in E. coli

Sub-part	BioBrick number
Additional basepairs
BioBrick prefix
Promoter	BBa_R0011
Ribosome-binding site	BBa_B0034
Secretion tag pelB	BBa_J32015
Pro-peptide + subtilisin E	BBa_K2020000
Terminator	BBa_B0010
BioBrick suffix
Additional basepairs

This construct was ordered at IDT as a gblock and named ‘EI0002’.

We decided to use the pSB1C3-backbone from iGEM. To amplify the backbone, we transformed BBa_J04450 (RFP expression system in a pSB1C3 backbone) in Escherichia coli BL21.

Figure 3: BBa_J04450 in pSB1C3. Picture taken from the Registry

Day 2

The ordered DNA sequence EI0002 was resuspended to a concentration of 20 ng/µL and amplified via PCR with the primers shown below.

Figure 4: Amplification of EI0002.

Multiple identical samples were prepared.

	temperature	duration	cycles

Initial denaturation	98°C	30 s
Denaturation	98°C	10 s	24 cycles
Annealing	Gradient from 55°C to 65°C	30 s
Elongation	72°C	90 s
Final elongation	72°C	10 min

Figure 5: PCR program.

Afterwards, the size of the PCR products was examined via agarose-gelelectrophoresis.

Figure 6: Agarose gel picture. PCR-amplified insert (column 1-12), DNA ladder #SM0312.

As all samples showed the correct size, the DNA concentration was increased by purification of multiple samples through one column during PCR clean-up.
In addition to this, multiple overnight cultures of 5 mL were prepared with the plates of the transformation from BBa_J04450 in E. coli BL21 from the day before. As controls, overnight cultures with E. coli BL21 wildtype were prepared, with and also without addition of antibiotic.

Day 3

	Growth?
Ligation product	Yes
Control 1: BL21 WT with antibiotic	No
Control 2: BL21 WT without antibiotic	Yes

Figure 7: Results of the overnight cultures. All controls were correct.

We prepared cryo cultures of the overnight cultures of BBa_J04450 in E. coli BL21 and isolated the plasmids from the cells for further experiments.

Day 4

In the following, we cloned the PCR-amplified, linear expression system EI0002 from day 1 into the pSB1C3 backbone of BBa_J04450. Both samples were digested with the enzymes EcoRI and PstI. After that, the samples were ligated for one hour at room temperature and then transformed into E. coli BL21. All controls were prepared according to the protocol.

Day 5

	Growth?
EI0002 in pSB1C3	Yes
Control 1: dephosphorylated backbone	No
Control 2: RFP	Yes
Control 3: BL21 WT without insert	No

Figure 8: Transformation results. All controls were correct.

To find a successfully ligated plasmid, we screened 24 colonies via Colony PCR with primers that bind outside of the insert to pSB1C3 and in parallel prepared overnight cultures of the same colonies. The samples were tested via agarose-gelelectrophoresis after the PCR.

Figure 9: Agarose gel picture of the colony-PCR. PCR-amplified insert (column 1-12), DNA ladder #SM0312, positive clones can be seen at the top in column 1, 11 and 12

A few colonies showed the correct size and were therefore used for further experiments. The overnight cultures of all negative colonies were discarded.

Day 6

	Growth?
EI0002 in pSB1C3	Yes
Control 1: BL21 WT with antibiotic	No
Control 2: BL21 WT without antibiotic	Yes
Control 3: BL21 WT without insert	No

Figure 10: Results of the overnight cultures. All controls were correct.

We prepared cryo cultures of the overnight cultures of the ligation product in E. coli BL21 and isolated the plasmids from the cells. The purified plasmids were sent in for sequencing.

Day 7

All sequenced samples show fatal mutations. Either frameshifts in the coding sequence or multiple deletions in the promoter occurred.
Despite repeating the experiment above multiple times, we were not able to obtain an expression system for subtilisin E without fatal mutations. Combined with the experience of other iGEM teams that the promoter BBa_R0011 shows some degree of expression before the addition of the inducer, we assumed that subtilisin E prohibits cell growth of E. coli if expressed in its active form.
As a result, we progressed by exchanging the promoter.

Day 8

To exchange to promoter of our expression system, we started with extracting parts of it via PCR. Hence, we used the primers shown below to obtain a sequence with the secretion tag, the subtilisin E gene and a terminator that is flanked by the BioBrick prefix and suffix.

Figure 11: Extraction of a part of the expression system via PCR.

Afterwards, we cloned this sequence in the BioBrick BBa_J04500 with the restriction sites EcoRI and PstI. BBa_J04500 is a protein expression backbone which consists of the lacI promoter BBa_R0010 and the ribosome-binding site BBa_B0034 integrated in the BioBrick standard vector pSB1C3. Then, we transformed the obtained construct in E. coli BL21 together with all needed controls.

Day 9

	Growth?
PCR extracted sequence in BBa_J04500	Yes
Control 1: dephosphorylated backbone	No
Control 2: RFP	Yes
Control 3: BL21 WT without insert	No

Figure 12: Transformation results. All controls were correct.

We prepared 5ml overnight cultures of the colonies and the usual controls.

Day 10

	Growth?
PCR extracted sequence in BBa_J04500	Yes
Control 1: BL21 WT with antibiotic	No
Control 2: BL21 WT without antibiotic	Yes

Figure 13: Results of the overnight cultures. All controls were correct.

At first, we prepared cryo cultures of the overnight cultures and then isolated the plasmids from the cells. In the following, we linearized the purified plasmids with EcoRI and tested their size via agarose-gelelectrophoresis.

Figure 14: Agarose gel picture of expression system with new promoter. Ligation products (column 1-5), DNA ladder #SM0312. Positive clones can be seen in column 3, 4 and 5.

The samples with the correct size were sent in for sequencing.

Testing the Expression

Day 1

For the analysis of the expression level we needed an empty backbone control. Hence, we digested BBa_J04450 with XbaI and SpeI and ligated the sample without addition of a further insert. The ligation product was then transformed in E. coli BL21.

Day 2

	Growth?
Empty backbone	Yes
Control 2: RFP	Yes
Control 3: BL21 WT without insert	No

Figure 1: Transformation results. All controls were correct.

Some colonies of the ligation product appeared to be pink. This was only possible due to a re-ligation of the RFP-expression cassette into pSB1C3. Therefore, these colonies weren’t used for further experiments. Only white colonies were used for the preparation of 5ml overnight cultures.

	Growth?
Empty backbone	Yes
Control 1: BL21 WT with antibiotic	No
Control 2: BL21 WT without antibiotic	Yes

Figure 2: Results of the overnight cultures. All controls were correct.

We prepared cryo cultures of the overnights of the empty backbone and purified the plasmids from the cells. Afterwards, we checked the size of the plasmids via agarose-gelelectrophoresis.

Figure 3: Agarose gel picture of the empty backbone pSB1C3 (column 1-2). DNA ladder #SM0312. Both clones are positive.

One of the samples that showed the correct size was sent in for sequencing.

Day 4

One of the samples of the PCR extracted expression system in BBa_J04500 that was sequenced beforehand and also the sample with the empty backbone showed the correct sequence and could therefore be used for further experiments.
To analyze the expression level of subtilisin E we prepared 20ml pre-cultures of the positive sample. In addition, we prepared pre-cultures of the E. coli BL21 wildtype and the pSB1C3 empty backbone in E. coli BL21 as controls.

Day 5

The pre-cultures from the day before were used to inoculate two 50ml main-cultures each to an OD₆₀₀ of 0.1. This main-cultures were then incubated at 37°C, 250 rpm until OD 0.3 was reached. Then, the main-cultures were induced by adding 0.5mM IPTG. Afterwards, one of the main-cultures was incubated at 30°C and the other at 25°C. We took samples of 500µL hourly and continued the incubation overnight.

Day 6

We took one sample of each main-culture from the day before and then lysed all samples in a sonication bath for about 30 minutes. The supernatant and the pellet of these samples were then tested separately via SDS-gelelectrophoresis.
Unfortunately, we were not able to obtain any clear results from the SDS gel and thus could not verify the expression of subtilisin E.

Testing the folding and activity

Day 1

We continued our experiments by performing a skim milk assay on agar plates. This assay utilizes the clearance of skim milk due to proteolysis to detect proteolytic activity. Therefore, we poured LB skim milk agar plates containing IPTG and the needed antibiotic and streaked the E. coli BL21 cells containing the plasmid with the expression system.

Figure 1: Skim milk plates assay. Cells containing the empty backbone (right) and cells containing the expression system for native subtilisin E (left) after incubation for 3 days at 30°C.

Comparing the clearance of the skim milk plates, a proteolytic activity could be observed for the cells containing the expression system for native subtilisin E. As a result, we concluded that within three days these cells are able to produce the native protease which will then digest the skim milk in the agar plates, resulting in a clearance.

Conclusion

We were able to express subtilisin E in E. coli in amount high enough to be detected via skim milk assay.

Mutating the expression system

This phase of the project had two aims:
At first, we wanted to show that both the active site and the pro-peptide cleavage site of subtilisin E are essential for the activity of the enzyme. Thus, we planned to simulate the incorporation of ONBY and DMNBS by exchanging both amino acids at the target sites against bigger amino acids and then to analyze the activity of the mutated enzyme as a proof of principle.
Our second goal was to mutate our current expression system in order to exchange serine in the active site and tyrosine in the pro-peptide cleavage site against the UAG amber stop codon in preparation for the expression of a photocaged enzyme.

Site-directed mutagenesis

Day 1
To prepare the expression of a photocaged protease and to prove our principle, we performed a site-directed mutagenesis. Four different strategies were pursued:

SDM	amino acid	DNA	amino acid	DNA
1.	serine > tyrosine	AGC > TAC
2.	serine > tyrosine	AGC > TAC	serine > DMNB-serine	TAC > TAG
3.	tyrosine > tryptophan	TAT > TAG
4.	tyrosine > ONB-tyrosine	TAT > TGG

Figure 1: Overview of different SDM strategies.

As a proof of principle we exchanged serine in the active site against tyrosine and tyrosine in the pro-peptide cleavage site against tryptophan. In preparation for the expression of a photocaged enzyme we exchanged the codons for the targeted amino acids against the UAG amber stop codon.
To achieve this, we simultaneously performed the site-directed mutagenesis three times (SDM 1, 3 and 4) with fitting primers and our expression system after the exchange of promoters as a template. SDM 2 had to be performed separately and with SDM 1 as a template at a later time.
For SDM 1, 3 and 4 we executed the following PCR:

	temperature	duration	cycles

Initial denaturation	98°C	30s
Denaturation	98°C	10s	3 cycles
Annealing	Gradient from 70°C to 90°C	30s
Elongation	72°C	3min 25s

Figure 2: PCR program 1.

	temperature	duration	cycles

Initial denaturation	98°C	30s
Denaturation	98°C	10s	15 cycles
Annealing	Gradient from 70°C to 90°C	30s
Elongation	72°C	3min 25s
Final elongation	72°C	10min

Figure 3: PCR program 2.

>

Multiple samples were prepared for each SDM. After completion of both PCR programs the size of all samples was verified via agarose-gelelectrophoresis

Figure 4: Agarose gel pictures of SDM 1 (top), 3 (middle) and 4 (bottom). DNA ladder #SM0312.

As all samples showed the correct size, identical samples were purified through one column during PCR clean-up to increase the DNA concentration.
After that, the DpnI digest was set up and incubated at 37°C overnight.

Day 2

In the beginning we performed a heatkill with the DpnI-digested samples of SDM 1, 3 and 4. Then, all samples were transformed in E. coli BL21 together with all needed controls.
Day 3

	Growth?
SDM 1, 3 and 4	Yes
Control 2: RFP	Yes
Control 3: BL21 WT without insert	No

Figure 5: Transformation results . All controls were correct.

Multiple 5ml overnight cultures were prepared for each SDM approach together with all needed controls.

Day 4

	Growth?
SDM 1, 3 and 4	Yes
Control 1: BL21 WT with antibiotic	No
Control 2: BL21 WT without antibiotic	Yes

Figure 6: Results of the overnight cultures. All controls were correct.

We prepared cryo cultures of the overnight cultures of SDM 1, 3 and 4 in E. coli BL21 and isolated the plasmids from the cells to use them for further experiments. A few samples were sent in for sequencing.

Day 5

The sequencing results showed that we were able to obtain samples with the desired, modified sequence. Hence, we used one sample with a confirmed sequence of SDM 1 as a template for SDM 2. In the following, we executed the following PCR:

	temperature	duration	cycles

Initial denaturation	98°C	30s
Denaturation	98°C	10s	3 cycles
Annealing	Gradient from 70°C to 90°C	30s
Elongation	72°C	3min 25s

Figure 7: PCR program 1.

	temperature	duration	cycles

Initial denaturation	98°C	30s
Denaturation	98°C	10s	15 cycles
Annealing	Gradient from 70°C to 90°C	30s
Elongation	72°C	3min 25s
Final elongation	72°C	10min

Figure 8: PCR program 2.

Multiple identical samples were prepared. After completion of both PCR programs the size of all samples was verified via agarose-gelelectrophoresis.

Figure 9: Agarose gel picture of expression system plasmid after SDM 2. DNA ladder #SM0312.

As all samples showed the correct size, identical samples were purified through one column during PCR clean-up to increase the DNA concentration.
After that, the DpnI digest was set up and incubated at 37°C overnight.

Day 6

We performed a heatkill with the DpnI-digested samples of SDM 2. Then, the sample was transformed in E. coli BL21 together with all needed controls.

Day 7

	Growth?
SDM 2	Yes
Control 2: RFP	Yes
Control 3: BL21 WT without insert	No

Figure 10: Transformation results. All controls were correct.

Multiple 5ml overnight cultures were prepared together with all needed controls.

Day 8

	Growth?
SDM 2	Yes
Control 1: BL21 WT with antibiotic	No
Control 2: BL21 WT without antibiotic	Yes

Figure 11: Results of the overnight cultures. All controls were correct.

We prepared cryo cultures of the overnight cultures of SDM 2 in E. coli BL21 and isolated the plasmids from the cells. Some samples were sent in for sequencing.

Day 9

The sequencing results showed that in some samples we successfully modified our expression system with the desired mutations.

Testing the expresion

In the following we wanted to analyze the expression level of the different, mutated versions of subtilisin E.
To express a photocaged enzyme not only a stop codon at the target site is needed but also an orthogonal tRNA/synthetase pair that incorporates the desired non-canonical amino acid in response to the amber stop codon. While targeting the pro-peptide cleavage site, we wanted to use the ONBY-tRNA/synthetase pair for E. coli which derives from the tyrosyl-tRNA/synthetase pair from Methanococcus janaschii. This year, the DNA sequence for the ONBY-tRNA/synthetase-pair was available on the iGEM kit plate as BioBrick BBa_K1416000. However, this part was only available in pSB1C3. This means, that the plasmids for both our expression system and the tRNA/synthetase-pair have the same origin of replication and therefore are competing against each other in terms of which of them will be replicated. Therefore, we weren’t able to use the BioBrick BBa_K1416000 for our experiments.
Fortunately, we were able to contact members of the former iGEM team Texas, Austin from 2014 who originally created the part BBa_K1416000. They sent us the ONBY-tRNA/synthetase pair in a backbone that carries a gentamicin resistance and is replicated with an ori that is not part of the same incompatibility group as the ori of pSB1C3.

Figure 1: Schematic representation of the recieved tRNA/synthetase pair in its backbone. Graphic obtained through iGEM team Texas, Austin 2014.

This allowed us to use the ONBY-tRNA/synthetase pair that is described as BBa_K1416000 without the need of cloning it into a different backbone.

Moreover, the experiments to test the incorporation efficiency of the ONBY-tRNA/synthetase pair showed that this pair is also able to incorporate DMNB-serine to a certain degree. This is why we decided to try to incorporate DMNBS in our SDM 4-modified enzyme with this tRNA/synthetase pair.

Day 1

We received the ONBY-tRNA/synthetase pair from team Texas, Austin 2014 as dried DNA on filter paper. At first, we cut the marked region from the filter paper, put it in a 1.5ml tube and immersed it in 100µl Tris-HCl pH 8.0. After incubation for 10 minutes, we used 2µl for a transformation in E. coli BL21 and in parallel transformed the usual controls.

Day 2

	Growth?
ONBY-tRNA/synthetase pair	Yes
Control 2: RFP	Yes
Control 3: BL21 WT without insert	No

Figure 2: Transformation results. All controls were correct.

Multiple 5ml overnight cultures were prepared for each SDM approach together with all needed controls.

Day 3

	Growth?
ONBY-tRNA/synthetase pair	Yes
Control 1: BL21 WT with antibiotic	No
Control 2: BL21 WT without antibiotic	Yes

Figure 3: Results of the overnight cultures. All controls were correct.

Cryo cultures of the ONBY-tRNA/synthetase pair in E. coli BL21 were prepared and we isolated the plasmids from the cells. One sample was sent in for sequencing.

Day 4

The sequencing results showed that the sample had the correct sequence and could therefore be used in further experiments.
In the following we executed a co-transformation in E. coli BL21:
SDM 2-modified expression system and ONBY-tRNA/synthetase pair
SDM 4-modified expression system and ONBY-tRNA/synthetase pair
During the transformation 2µl of each plasmid sample were used and the cells were plated on LB agar plates with two antibiotics.

Day 5

	Growth?
Co-transformation	Yes
Control 2: RFP	Yes
Control 3: BL21 WT without insert	No

Figure 4: Transformation results. All controls were correct.

We prepared multiple 5ml overnight cultures of each co-transformation together with the needed controls.
As the transfer from the solid complex medium to liquid minimal medium causes a high stress-level for the E. coli cells, we intended to change at first from solid complex medium to solid minimal medium and then to liquid minimal medium. Hence, we streaked the same colonies that we used for the overnight cultures on M9 agar plates.

Day 6

	Growth?
Co-transformation	Yes
Control 1: BL21 WT with antibiotic 1	No
Control 2: BL21 WT with antibiotic 2	No
Control 3: BL21 WT with antibiotic 1 + 2	No
Control 4: BL21 WT without antibiotics	Yes

Figure 5: Results of the overnight cultures. All controls were correct.

To back up the co-transformed cells in M9 medium we prepared cryo cultures of the overnight cultures. As the cells were able to grow in medium with two antibiotics, both plasmids must have been successfully transformed into them. As a consequence, these cells can be used for further experiments. Continuing the transfer to liquid minimal media, we prepared 5ml overnight cultures with the positive clones from the M9 agar plates in liquid M9 medium.

Day 7

In the following we wanted to start with the analysis of the expression level. For that reason, we prepared different pre-cultures:
SDM 1-modified expression system in complex media
SDM 2-modified expression system + ONBY-tRNA/synthetase pair in minimal media
SDM 3-modified expression system in complex media
SDM 4-modified expression system + ONBY-tRNA/synthetase pair in minimal media
Empty backbone pSB1C3 in complex media
Empty backbone pSB1C3 in minimal media
E. coli BL21 wildtype in complex media
E. coli BL21 wildtype in minimal media
All pre-cultures were incubated at 37°C, 250 rpm overnight.

Day 8

We then proceeded to prepare two 50ml main-cultures for each pre-culture from the day before. All main-cultures were prepared with the same medium as the pre-culture. To the cultures with minimal medium we added the non-canonical amino acid solved in 50% DMSO. Also, these cultures had to be handled in the dark after addition of the non-canonical amino acids due to their light-sensitivity.

Main-culture	Non-canonical amino acid
SDM 2 + ONBY-tRNA/synthetase pair	ONB-tyrosine
SDM 4 + ONBY-tRNA/synthetase pair	DMNB-serine
Empty backbone pSB1C3	ONB-tyrosine
E. coli BL21 wildtype	ONB-tyrosine

Figure 6: Overview of addition of non-canonical amino acids to the main-cultures.

All main-cultures were inoculated to an OD₆₀₀ of 0.1 and incubated at 37°C, 250 rpm to OD₆₀₀ 0.3. Then, the main-cultures were induced by adding 0.5mM IPTG. Afterwards, one of each type of main-culture was incubated at 30°C and the other at 25°C. We took five identical samples of 500µL of each main-culture hourly and continued the incubation overnight.

Day 9

We took five identical samples of each main-culture from the day before and then lysed all samples with different cell lysis methods:
Lysozyme solution (1h, 37°C, 250 rpm)
Lysozyme solution (1h, 37°C, 250 rpm) + sonication bath (30 minutes)
Sonicator (3 minutes)
Glass beads mill (10 minutes)
The supernatant of these samples was then tested via SDS-gelelectrophoresis. Unfortunately, we were not able to obtain any clear results from the SDS gel and thus could not verify the expression of subtilisin E.

Testing the folding and activity

Day 1

As we were not able to detect the expression of the modified proteases via SDS gel, we proceeded by executing a skim milk assay on agar plates containing IPTG and the needed antibiotics. Therefore, we streaked the cells containing the modified expression systems on these plates and incubated at 30°C for three days.

Figure 1: Skim milk plates assay. Cells producing the native protease (picture A-C, left) in comparison to either cells containing the empty backbone (picture A, right) or cells carrying the SDM 3-modified (picture B, right) and the SDM 1-modified expression system (picture C, right) after incubation for 3 days at 30°C.

Neither the empty backbone nor the SDM 1-modified expression system did seem to cause a proteolytic activity. A clearance and therefore a proteolytic activity could only be observed for the native protease (as demonstrated before) and the SDM 3-modified expression system.
Via SDM 1 we exchanged the targeted serine in the active site against a bigger amino acid, namely tyrosine. By demonstrating that this modification doesn’t result in a clearance of the skim milk plates, we were now able to prove that serine is essential for the proteolytic activity of the protease and that exchanging it would inactivate the enzyme.
SDM 3 has been executed to exchange tyrosine in the pro-peptide cleavage site against tryptophan, a bigger amino acid. As seen on the pictures above, a clearance has occurred for those modified cells and a proteolytic activity could be assumed. Contrary to our former beliefs, it could now be deduced that exchanging tyrosine doesn’t result in a change of activity. Consequently, tyrosine in the pro-peptide cleavage site is not essential for the activity of subtilisin E.

Conclusion

We were able to proof that serine in the active site would result in a loss of activity. Hence, we demonstrated that exchanging serine against a photo-labile, non-canonical amino acid will inactivate subtilisin E and therefore proved the principle of our project.
Unfortunately, we were not able to prove the principle of our project regarding tyrosine in the pro-peptide cleavage site, as it seems to be not essential for the proteolytic activity. Thus, exchanging tyrosine against ONB-tyrosine will not influence the activity of the enzyme.

Photoclevage

This part of the project was dedicated to the actual photocaging of the protease. Unfortunately, we were not able to execute all of the experiments that we planned due to a lack of time. But as we were able to prove the concept of our project, we will not only show our progress so far but also our plans for the experiments that we weren't able to conduct.

Irradiation

Day 1

To characterize O-(2-nitrobenzyl)-L-tyrosine (ONBY), we decided to test the photocleavage with the light box provided by the iGEM team Düsseldorf 2016 and to analyze it, using gas chromatography-mass spectrometry (GC-MS). To achieve this, we dissolved 5mg of ONBY powder in 100µl pyridine and incubated at 37°C for 10 minutes. Then, the analysis was executed via GC-MS with the following conditions:

Injection Temperature: 80°C; Holding Time: 2 minutes
Final Temperature: 250°C; Temperature Ramp: 8°C

The sample was then exposed to UV light of intensity 14.8 mW/cm² with different exposure time of 1, 3, 5 and 10 minutes using the light box and then analyzed using the same GC-MS method described above. The exposure resulted in photocleavage, and produced 2-nitroso benzaldehyde which has a molecular weight of 132.122 g/mol. Compounds with similar molecular weight have an elution time of 5.3 minutes.

Figure 1: Chromatograms of the analysis via GC-MS of ONBY. Chromatogram of pyridine as a blank (A) and ONBY after 0 (B), 1 (C), 3 (D), 5 (E) and 10 minutes (F) of exposure time.

The chromatogram of the analyzed samples shows the appearance of a peak at 5.22 minutes close to the expected elution time of 5.3 minutes. We observed that, as the exposure time was incremented from 1 minutes to 10 minutes (figure 1, graph C-F), the intensity of the peak also amplified indicating an increase in the amount of cleavage product. Also the absence of this peak in pyridine (blank) and the sample without exposure (figure 1, graph A and B), supports the absence of cleavage product. However, due to the unavailability of standard 2-nitroso benzaldehyde, we could not quantify the amount of cleaved product produced on UV exposure. The spectrum of the cleaved product show peaks at 51, 52, 73 and 79 m/z (figure 2) which is almost similar to the data available. [1]

Figure 2: Spectrum of 2-nitroso benzaldehyde for peak at 5.22 minutes.

A rough estimate of the change in concentration was made by measuring the area under the curve for the peak at 5.22 minutes (figure 3).

Figure 3: Increase in area under curve for peak at 5.22 minutes.

Also based on similar measurements, we observed a decrease in area for the peak at 19.02 minutes, indicating the presence and decrease in the concentration of ONBY (figure 4).

Figure 4: Decrease in area under curve for peak at 19.02 minutes.

As a conclusion, we deduced that the amount of cleavage product increases as the exposure time is extended.

Day 2

We intended to use the results of the ONBY photocleavage characterization to irradiate our samples S221X- and Y77X-mutated proteases which were obtained through cultivation of the SDM 2 and SDM 4-modified expression system in E. coli BL21. Furthermore, we planned to perform a skim milk assay with these samples before and after irradiation and then the degradation efficiencies of the proteases were compared by the extent of clearance. With these results we wanted to prove that due to the incorporation of DMNB-serine in the catalytic triade of the protease would lose its proteolytic activity and would only re-gain it after irradiation which would result into photocleavage.

Synthetase - Incorporating DMNBS in E. coli

Research on screening system. Decision to work with kit from iGEM Team Austin, Texas 2014

The development of a screening system, which was needed to test for the activity of a synthetase incorporating a ncAA, is a difficult and time consuming task. Therefore, we used a reporter plasmid, which was established and characterized by iGEM Team Austin, Texas, 2014. It offers the opportunity to approximate incorporation values based on fluorescence proteins.
The reporter plasmid codes for mRFP1 and sfGFP which are IPTG inducible. mRFP1 is linked to sfGFP by a sequence which includes the amber stop codon. mRFP1 is (if induced) expressed constitutively and if the orthogonal mutated synthetase is capable of recognizing the ncAA and loading it on the tRNA with the amber anticodon, is followed by sfGFP. Else, the expression stops at the amber stop codon in the linker.

Definition of Incubation Conditions

Decision for host strain
An amberless E. coli strain has been developed which only expresses proteins with stop codons excluding the amber stop codon. For our purpose we chose not to work with this strain. In our working strain E. coli BL21 DE3 gold the release factor 1 competes with the tRNA loaded with the ncAA. Still enough proteins with the amber as a stop codon are expressed funtionally. Moreover, the affinity of the tRNA to the amber stop codon on the mRNA is high enough to incorporate the ncAA in any target protein.

Arrival and Preparation of Test Kit with DNA from Texas
After receiving the test kit the plasmids were recovered in TRIS buffer pH 8.5. The diluted DNA was then transformed in E. coli BL21 DE3 gold cells which were cultivated on LB solid plates. After 1 Day of growth the cells were prepared as overnight cultures. Following the incubation, plasmids were isolated according to protocol.

Preparation of Chemical Competent Cells hosting the reporter plasmid pRXG
The reporter plasmid pRXG was transformed onto LB plates. Subsequently, some colonies were picked for overnight cultures. Thereof cryo cultures were prepared. The plasmids were isolated and sent for sequencing. The cryo cultures were then used to inoculate precultures and prepare chemical competent cells according to the protocol.

Determining Concentration of Antibiotics in LB
The growth of E. coli cells transformed with plasmids containing wild type tyrosyl-tRNA/synthetase and oNBY-tRNA/synthetase on LB solid as well as in LB liquid is not affected by concentrations of gentamicin up to 30 µg/ml, whereas a wild type E. coli BL21 DE3 gold is affected already at 5 µg/ml. Hence, appropriate concentration for gentamicin plates and cultures is 30 µg/ml. This observation is also valid for 50 µg/ml kanamycin tested with transformed reporter plasmids in E. coli BL21 DE3 gold.
Furthermore the combination of the two antibiotics is evaluated. Since the cells showed a proper growth rate in LB with 30 µg/ml gentamicin + 50 µg/ml kanamycin when transformed with a reporter plasmid and a synthetase plasmid the assessed concentrations are kept.

Figure 1: antibiotics test - growth on plates with gentamicin in concentrations: 30, 35, 40, 45, 50 µg/ml

Determining Concentration of Antibiotics in M9 Minimal Medium
By cultivation of cells transformed with one of the two types of plasmids (antibiotic resistances: kanamycin/gentamicin) and incubating on plates with different antibiotics concentrations the correct working concentrations were found. After having tested the growth on plates we cultivated the cells in liquid medium with the same antibiotics concentrations to also check it under this conditions. For this determination we evaluated the growth on the plates and in the test tubes. To make sure the cells kept the plasmids we performed a colony PCR (plates) or plasmid isolation (liquid) followed by gel electrophoresis.(picture) With the found concentrations we performed the same experiment but with both plasmids and antibiotics at the same time to find a proper concentration combination of both antibiotics. It was high enough to have an appropriate pressure on the cells, but was low enough, so that cultivation was possible in minimal medium.
The growth on microtiter plates was as well evaluated via plate reader.
Our chosen concentration where E. coli is growing and reliably keeps both plasmids can be found in the following list.

Concentrations used in M9 solid medium with E. coli BL21 DE3 gold:

Gentamicin 10 µg/ml
Kanamycin 50 µg/ml

Concentrations used in M9 liquid medium with E. coli BL21 DE3 gold:

Gentamicin 5 µg/ml and
Kanamycin 10 µg/ml

Testing Transformation Efficiency
To get a maximum of colonies with transformation of the mutant library, the following tranformation methods were tested:

A) co-transformation of both plasmids at the same time: reporter + tRNA/synthetase plasmid
B) transformation of chemical competent cells (already hosting the reporter plasmid) with tRNA/synthetase plasmid

Conclusion: To have both plasmids in one cell, the best solution is the transformation of the tRNA/synthetase plasmid as PCR product (deriving from mutagenesis PCR) in competent cells which already contain the reporter plasmid pRXG. Colonies appear smaller in comparison to E. coli BL21, because they have two additional plasmids resulting in metabolic burden and hence a lower growth rate. Compared to co-transformation, the number of cells is higher by a factor of 10.

Testing Various Cultivation Steps
As transformation on LB solid with subsequent picking in M9 liquid resulted in almost no growth, proper cell growth is achieved by the following method:

Pick into M9 liquid: Masterplate, growth: 2 days at 30°C, 900rpm,
Replicate into M9 liquid Screening plate, growth 2 days at 30°C, 900 rpm
1. For positive screening:
  1. Induction with 100 µM IPTG
  2. 2mM DMNBS
2. For negative screening:
  1. Induction with 100 µM IPTG

Cryo cultures are made from all intermediate steps.

Dissolving DMNB-serine (DMNBS)
DMNBS is soluble in 50% DMSO at basic pH. A stock of 50mM is prepared and used with a final concentration in M9 of 2 mM resulting in a pH value of 7.55.

Determining Growth with DMNBS
Cultivating E. coli BL21 DE3 gold containing two different plasmids shows lower growth rates when adding 100µM IPTG and 2mM DMNBS to M9 minimal medium, resulting in an overall growth time of 42-48h.

Modelling of Binding Pocket of DMNBS-Synthetase

We did research on already published mutated synthetases and chose the wild type Methanococcus jannaschii tyrosyl tRNA/synthetase pair to mutate for DMNBS specificity. This pair has already been reported to be orthogonal in E. coli and was mutated for the use with other ncAAs.
By computational analysis and comparison to the E. coli leucyl tRNA/synthetase pair which has been changed to DMNBS affinity, amino acids in the binding pocket were identified. These needed to be mutated to achieve DMNBS specificity in the Methanococcus jannaschii tyrosyl tRNA/synthetase pair. We were lucky that the synthetase backbone was not affected by the size of the ncAA. The other mutation sites were determined with respect to chemical properties, space for the photoprotection group and codon usage of E. coli.

Figure 1: ncAA (DMNB-serine) in binding pocket of Methanococcus jannaschii tyrosyl synthetase

SDM Site Directed Mutagenesis

Tyrosine at position 32 was mutated to glycine by site directed mutagenesis with a full gradient two step PCR. Elongation time was set to 50 sec/kbp.

	temperature	duration	cycles

Initial denaturation	98°C	30s
Denaturation	98°C	10s	3 cycles
Annealing	Gradient from 61°C to 71°C	45s
Elongation	5 min

Figure 1: PCR program 1

	temperature	duration	cycles

Initial denaturation	98°C	30s
Denaturation	98°C	10s	15 cycles
Annealing	Gradient from 61°C to 71°C	45s
Elongation	72°C	5 min
Final elongation	72°C	10min

Figure 2: PCR program 2

Gel electrophoresis of the PCR product showed a successful amplification at the expected length.

Figure 3: Gel electrophoresis of Site Directed Mutagenesis showing a PCR product at the expected length at 5321 bp

0: ladder
1-11: temperature gradient: 61-71°C
The tubes were pooled, cleaned and transformed into E. coli BL21 DE3 gold. The plates were used to prepare overnight cultures and on the following day, the plasmids were isolated. Sequencing results showed in 4 out of 4 colonies the successful replacement of the tyrosine by the glycine codon.

SSM1 Site Saturated Mutagenesis 1

The isolated plasmid from SDM (Tyr32Gly) was used as template for further site saturated mutagenesis. A full gradient two step PCR with an elongation time of 50 sec/kbp was performed on site L65 due to its location within the 2 Å radius of DMNBS. The subsequent gel electrophoresis showed the PCR product at the expected length.

Figure 1: Gel electrophoresis of Site Saturated Mutagenesis 1 showing a PCR product at the expected length of 5321 bp

The tubes were pooled and cleaned and the product was transformed into E. coli BL21 DE3 gold. The sequencing of 4 colonies showed in all 4 samples the successful mutation at the SSM1 site to various amino acids as well as the glycine codon mutation at position 32.

SSM2 Site Saturated Mutagenesis 2

With the purpose of performing Site Saturated Mutagenesis the colonies of SSM1 were washed off the transformation plates. The isolated plasmid was used as template for SSM2 (mutation sites D158 and I159). The first site was to be mutated due to known H-bonds of the tRNA/synthetase complex with the former ligand tyrosine. Second site had a sidechain, which was located within the 2 Å radius of DMNBS. The primers contain two partially randomized codons. A full gradient two step PCR was performed with an elongation time of 50 sec/kbp. Subsequent gel electrophoresis showed a PCR product at the expected length. The tubes were pooled and the product was isolated and subsequently transformed into E. coli BL21 DE3 gold. 4 out of 4 colonies were sequenced and the results still showed a glycine codon in SDM position as well as different mutations in various combinations at the three SSM sites.

Figure 1: Gel electrophoresis of Site Saturated Mutagenesis 2 showing a PCR product at the expected length at 5321 bp

SSM3 Site Saturated Mutagenesis 3

Colonies were washed off the transformation plates from SSM2. Plasmids were isolated and used as template for Site Saturation Mutagenesis 3. A full gradient two step PCR is performed with 50 sec/kbp elongation time. Gel electrophoresis showed the PCR product to be at the expected length.

Figure 1: Gel electrophoresis of Site Saturated Mutagenesis 3 showing a PCR product at the expected length at 5321 bp

Mutant Library

For purposes of sequencing 12 transformations of the mutation library into E. coli BL21 DE3 gold were made and all results showed different codons in various combinations at all mutation sites, respectively a glycine at position 32. That means, all of our mutagenesis PCRs worked.
The samples were pooled and the cleaned up PCR product was transformed into the competent cells already containing the reporter plasmid. They were streaked on M9 plates with the assessed concentrations of antibiotics for selection. After two days of incubation appropriate colonies were picked into microtiter plates containing M9 liquid Medium and respective antibiotics. Thus over 8000 clones were collected. The microtiterplates were incubated and used for inoculation of a second microtiter plate. A final inoculation into black microtiter plates with transparent bottom for screening followed this preculture. Induction with 100 µM IPTG as well as supplementation of 2 mM DMNBS was carried out at the beginning of this final cultivation (see results).

Figure 1: Sequencing results showing various mutations in saturated mutation spots with different combinations of codons. Aligned with Geneious 9.0.5.

Determine measurement conditions and parameters

Excitation and emission spectra of mRFP1 and sfGFP were obtained from fluorescence scan measurements (figure 1, figure 2). To get green and red fluorescence signals E. coli BL21 DE3 gold was transformed with the reporter plasmid pRXG and synthetase plasmid (wild type tyrosyl-tRNA/synthetase pair). The tRNA/synthetase pair coded by this plasmid (YRS) is the natural synthetase for incorporation of tyrosine, whereas the anticodon of the tRNA is mutated to recognize the amber stop codon. As a result, the linker downstream of mRFP1 is synthesized, harbouring tyrosine at the amber codon site. Following the linker, sfGFP is also expressed an its fluorescence signal is used to determine the correct wavelength for screening.

Figure 1: normalized fluorescence spectrum of mRFP1 - dotted line representing excitation and continuous line representing emission

Figure 2: normalized fluorescence spectrum of sfGFP - signal for successful amino acid incorporation by tRNA/synthetase pair via amber supression with dotted line representing excitation and continuous line representing emission

For screening the following wavelength settings were used:

OD: 600 nm

sfGFP:
excitation: 480 nm
emission: 508 nm

mRFP1:
excitation: 584 nm
emission: 605 nm

Screening

As a prescreening setup an endpoint detection of OD and fluorescent intensities with a plate reader was chosen. Excitation and emission spectra of mRFP1 and sfGFP were obtained from a previously conducted measurement.

Thus a preselection of DMNBS tRNA/synthetase mutants was determined. A rescreening of mutants with promising effiency and fidelity was performed, to which an additional online measurement was made to obtain scattered light values as well as fluorescence intensities over time. This was carried out by an online measurement screening platform.

Analysis

The DMNBS synthetase variants were evaluated by normalizing GFP fluorescence levels to the wild type tyrosyl synthetase and comparing the mutants to each other. Thus incorporation efficiency and fidelity values were obtained.

Figure 1: Efficiency (dark green) and fidelity (light green) of various DMNBS mutants normalized to wild type Mj tyrosyl synthetase

These variants were sent for sequencing to obtain and discuss properties of amino acids which occur at the mutation spots. See this link for results.

@@ Line 30: / Line 30: @@
              <h1 style="padding-left: 0.8cm;" >Lab Book</h1>
          </div>
-  <p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;">To express a photocaged protease in our case subtilisin E, we developed three lab strategies. Their milestones can be seen below in three different timelines, one for every sub-division. Details about reaching these milestones will become visible, if you click on the corresponding circles. On the page <a href="https://2016.igem.org/Team:Aachen/Description"><span style="color:#0000EE;">Project Idea</span></a> the theory beneath our lab work is described and on the subpage <a href="https://2016.igem.org/Team:Aachen/Lab/Protocols"><span style="color:#0000EE;">Protocols & Methods</span></a> the exact protocols can be seen, if you would like to repeat the experiments.It can also be helpful to have a look at our <a href="https://static.igem.org/mediawiki/2016/7/75/T--Aachen--primerslist.pdf"><span style="color:#0000EE;">primers list</span></a>.
+  <p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;">To express a photocaged protease, in our case subtilisin E, we developed three lab strategies. Their milestones can be seen below in three different timelines, one for every sub-division. Details about reaching these milestones will become visible, if you click on the corresponding circles. On the page <a href="https://2016.igem.org/Team:Aachen/Description"><span style="color:#0000EE;">Project Idea</span></a> the theory beneath our lab work is described and on the subpage <a href="https://2016.igem.org/Team:Aachen/Lab/Protocols"><span style="color:#0000EE;">Protocols & Methods</span></a> the exact protocols can be seen, if you would like to repeat the experiments. It can also be helpful to have a look at our <a href="https://static.igem.org/mediawiki/2016/7/75/T--Aachen--primerslist.pdf"><span style="color:#0000EE;">primers list</span></a>.
 </p>
 </div>
@@ Line 36: / Line 36: @@
 <div class=" content_area structure">
              <div class="single_header_title">
-                 <h1 style="padding-left: 0.8cm;"><a name="scerevisiae"class="anchor">Saccharomyces cerevisiae - targeting serine</a></h1>
+                 <h1 style="padding-left: 0.8cm;"><a name="scerevisiae"class="anchor">Photocaging - Targeting Serine in <i>Saccharomyces cerevisiae</i> </a></h1>
              </div>
 <br/>
@@ Line 121: / Line 121: @@
 <div class="yeastcircle1">
-<h2 style="border-bottom: 5px solid #005b04;padding-left: 1.0cm;">Expression of subtilisin E
+<h2 style="border-bottom: 5px solid #005b04;padding-left: 1.0cm;">Expression of Subtilisin E
 </h2>
 <br/>
@@ Line 133: / Line 133: @@
 <br/>
 <p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;">
-<b style="color:Black;"> Strain selection </b><br/>
+<b style="color:Black;"> Strain Selection </b><br/>
 <p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;"><i>S. cervisiae </i><br/>
@@ Line 139: / Line 139: @@
 * needs to have the deficiencies of both chosen vectors<br/><br/>
-<span style="color:#005b04;"> Characterization of strand </span> [<a href="#ref1LB "><u style="color:#0000EE; ">1</u></a>]<br/>
+<span style="color:#005b04;"> Characterization of Strand </span> [<a href="#ref1LB "><u style="color:#0000EE; ">1</u></a>]<br/>
 <table align="center" style="width:90%; border:2pt solid black;margin-left: auto; margin-right: auto;">
@@ Line 157: / Line 157: @@
 <p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;">
-<span style="color:#005b04;">Growth&nbsp;–&nbsp;temperature </span><br/>
+<span style="color:#005b04;">Growth&nbsp;–&nbsp;Temperature </span><br/>
 We tested the growth in different temperatures for optimization:<br/>
@@ Line 188: / Line 188: @@
 <p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;">
 The <i>S. cerevisiae </i> strand only grew at 30°C.<br/><br/>
-<span style="color:#005b04;"> Growth&nbsp;–&nbsp;media </span><br/>
+<span style="color:#005b04;"> Growth&nbsp;–&nbsp;Media </span><br/>
 As our CENPK2-1D strand was growing poorly in the SC-U medium, we got the advice to try the same medium but with a higher amount of amino acids (SD-U).<br/>
@@ Line 217: / Line 217: @@
 After OD measurements it was obvious, that the SD-U medium gave the CENPK2-1D better conditions for growth<br/><br/>
-<span style="color:#005b04;"> Growth &nbsp;–&nbsp;protection against contamination </span><br/>
+<span style="color:#005b04;"> Growth &nbsp;–&nbsp;Protection against Contamination </span><br/>
 To prevent bacterial contaminations, we made a comparison of the growth of our used strand in medium with and without ampicillin.  <br/>
@@ Line 245: / Line 245: @@
-<br/><b style="color:Black;"> Selection of vector </b><br/><br/>
+<br/><b style="color:Black;"> Selection of Vector </b><br/><br/>
-<span style="color:#005b04;"> Requirements for vector </span><br/>
+<span style="color:#005b04;"> Requirements for Vector </span><br/>
 <p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;">
@@ Line 257: / Line 257: @@
 For amplifying the vector easily it needs to have an ori and selective marker in <i>E. coli</i><br/><br/>
-.&nbsp;Selection System in yeast <br/>
+.&nbsp;Selection system in yeast <br/>
 different than the selection of synthetase plasmid which is tryptophane auxotrophy<br/>
 auxotrphy must be different from trytophane <br/><br/>
-<span style="color:#005b04;"> Available vector for us:</</span><br/>
+<span style="color:#005b04;"> Available Vectors for Us:</</span><br/>
 <center><img src="https://static.igem.org/mediawiki/2016/e/e9/T--Aachen--pTEFMF2.png" style="margin-bottom-30px; margin-top:-0px; margin-left:125px;"></center>
@@ Line 418: / Line 418: @@
 After cloning the subtilisin E into the vectors pTEF-MF, pyes2 and the genome integration vector pCfB255 [<a href="#ref4LB "><u style="color:#0000EE; ">1</u></a>] a test expression was made. We used the following methods to test for proteolytic activity:<br/><br/>
-<b style="color:#005b04; ">Skim Milk assay</b><br/>
+<b style="color:#005b04; ">Skim Milk Assay</b><br/>
 The skim milk assay is a non specific test for proteolytic activity. Lysis of casein leads to a clear solution while the solution remains white when the proteolytic activity is missing.
 <br/><br/>
-<b style="color:#005b04; ">AAPF assay</b><br/>
+<b style="color:#005b04; ">AAPF Assay</b><br/>
 The AAPF assay is a very specific test for proteolytic activity in serine proteases.
 <br/><br/>
-<b style="color:#005b04; ">TCA precipitation </b><br/>
+<b style="color:#005b04; ">TCA Precipitation </b><br/>
 It is used to precipitate proteins from cell culture supernatant to gain a higher concentration.
 <br/><br/>
-<b style="color:#005b04; ">SDS gel</b><br/>
+<b style="color:#005b04; ">SDS Gel</b><br/>
 An SDS gel can be used to make proteins visible. SDS (sodiumdodecyl-sulfate) charges all proteins negative, so that they migrate in an electric field. It is a size based sorting method.
 <br/><br/>
@@ Line 436: / Line 436: @@
 Subtilisin E expression was not possible in this expression system.
 <br/><br/>
-<b style="color:Black; ">Results in pyes2</b><br/>
+<b style="color:Black; ">Results in pYES2</b><br/>
 In the pyes2 vector with additional MFalpha secretion tag Subtilsin E also should be secreted.
 We tested the vector like pTEF-MF except we induced it first with 20 % Galactose and fed 20 % again after every 24h.
 <br/><br/>
-<b style="color:Black; ">Results in pcfB255[<a href="#ref3LB"><u style="color:#0000EE;">1</u></a>]</b><br/>
+<b style="color:Black; ">Results in pCFB255[<a href="#ref3LB"><u style="color:#0000EE;">1</u></a>]</b><br/>
 Tests were performed just like the pTEF-MF, but also genome integration did not result in secretion of an active protease.
@@ Line 571: / Line 571: @@
 <p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;">
 <span style="color:#005b04;">Agarose Gel</span><br/>
-We made an agarose gel to see if our modified Subtilsin E was amplified with the primers. The expected size is 7 700 bp.
+We made an agarose gel to see if our modified subtilsin E was amplified with the primers. The expected size is 7 700 bp.
 <br/>
 <center><img src="https://static.igem.org/mediawiki/2016/f/fb/T--Aachen--220716.jpg"/></center>
@@ Line 752: / Line 752: @@
 <tr>
 <td style="height:600px;">
-<img src=" https://static.igem.org/mediawiki/2016/7/73/T--Aachen--260716yeastSynthetase.jpg ">
+<img src=" https://static.igem.org/mediawiki/2016/b/bc/T--Aachen--260716yeastSynthetase%282%29.jpg " >
 </td>
 <td style="height:600px;">
-<img src=" https://static.igem.org/mediawiki/2016/b/bc/T--Aachen--260716yeastSynthetase%282%29.jpg " >
+<img src=" https://static.igem.org/mediawiki/2016/7/73/T--Aachen--260716yeastSynthetase.jpg ">
 </td>
 </tr>
@@ Line 844: / Line 844: @@
 <div class=" content_area structure">
              <div class="single_header_title">
-                 <h1 style="padding-left: 0.8cm;"><a name="ecoli"class="anchor">Escherichia coli - targeting tyrosine</a></h1>
+                 <h1 style="padding-left: 0.8cm;"><a name="ecoli"class="anchor">Photocaging - Targeting Tyrosine in <i>Escherichia coli</i> </a></h1>
              </div>
 <br/><br/>
@@ Line 1,018: / Line 1,018: @@
 </tr>
 </table>
-<figcaption style="text-align:center; font-size: 15px; padding-left:2cm;padding-right:2cm; "><b>Figure 5: sPCR program.</b></figcaption><br/>
+<figcaption style="text-align:center; font-size: 15px; padding-left:2cm;padding-right:2cm; "><b>Figure 5: PCR program.</b></figcaption><br/>
 <p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;">
 Afterwards, the size of the PCR products was examined via agarose-gelelectrophoresis.
@@ Line 1,141: / Line 1,141: @@
 </tr>
 <tr>
-<td style="border:2pt solid black;">Control 3: BL21 WT without inser</td>
+<td style="border:2pt solid black;">Control 3: BL21 WT without insert</td>
 <td style="border:2pt solid black;">No</td>
 </tr>
@@ Line 1,259: / Line 1,259: @@
 <p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;">
 <b><span style="color: #005C04;">Day 1</span></b><br/><br/>
-We continued our experiments by performing a skim milk assay on agar plates. Therefore, we poured LB skim milk agar plates containing IPTG and the needed antibiotic and streaked the <i>E. coli</i> BL21 cells containing the plasmid with the expression system.
+We continued our experiments by performing a skim milk assay on agar plates. This assay utilizes the clearance of skim milk due to proteolysis to detect proteolytic activity. Therefore, we poured LB skim milk agar plates containing IPTG and the needed antibiotic and streaked the <i>E. coli</i> BL21 cells containing the plasmid with the expression system.
-<center><img src="https://static.igem.org/mediawiki/2016/f/fb/T--Aachen--labbook_ecoli_skim_milk_native.png" style="width:600px;"/></center>
+<center><img src="https://static.igem.org/mediawiki/2016/b/bc/T--Aachen--Skim_Milk_plate_1.png" style="width:300px;"/></center>
-<figcaption style="text-align:center; font-size: 15px; padding-left:2cm;padding-right:2cm; "><b>Figure 1: Skim milk plates assay.</b> Cells containing the empty backbone (left) and cells containing the expression system for native subtilisin E (right) after incubation for 3 days at 30°C.</figcaption>
+<figcaption style="text-align:center; font-size: 15px; padding-left:2cm;padding-right:2cm; "><b>Figure 1: Skim milk plates assay.</b> Cells containing the empty backbone (right) and cells containing the expression system for native subtilisin E (left) after incubation for 3 days at 30°C.</figcaption>
 <p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;">
-Comparing the clearance of the skim milk plates, a proteolytic activity could be proven for the cells containing the expression system for native subtilisin E. As a result, we concluded that within three days these cells are able to produce the native protease which will then digest the skim milk in the agar plates, resulting in a clearance.
+Comparing the clearance of the skim milk plates, a proteolytic activity could be observed for the cells containing the expression system for native subtilisin E. As a result, we concluded that within three days these cells are able to produce the native protease which will then digest the skim milk in the agar plates, resulting in a clearance.
 <br/><br/>
@@ Line 1,565: / Line 1,565: @@
 <b><span style="color: #005C04;">Day 6</span></b><br/><br/>
-We performed a heatkill with the DpnI-digested samples of SDM 2. Then, the sample was transformed in <i>E. coli</i> BL21 together with all needed controls.<br/><br/>
+We performed a heatkill with the DpnI-digested samples of SDM 2. Then, the sample was transformed in
+<i>E. coli</i> BL21 together with all needed controls.<br/><br/>
 <b><span style="color: #005C04;">Day 7</span></b>
@@ Line 1,627: / Line 1,628: @@
 In the following we wanted to analyze the expression level of the different, mutated versions of subtilisin E. <br/>
 To express a photocaged enzyme not only a stop codon at the target site is needed but also an orthogonal tRNA/synthetase pair that incorporates the desired non-canonical amino acid in response to the amber stop codon. While targeting the pro-peptide cleavage site, we wanted to use the ONBY-tRNA/synthetase pair for <i>E. coli</i> which derives from the tyrosyl-tRNA/synthetase pair from <i>Methanococcus janaschii</i>. This year, the DNA sequence for the ONBY-tRNA/synthetase-pair was available on the iGEM kit plate as BioBrick <a href=”http://parts.igem.org/Part:BBa_K1416000”>BBa_K1416000</a>. However, this part was only available in pSB1C3. This means, that the plasmids for both our expression system and the tRNA/synthetase-pair have the same origin of replication and therefore are competing against each other in terms of which of them will be replicated. Therefore, we weren’t able to use the BioBrick BBa_K1416000 for our experiments. <br/>
-Fortunately, we were able to contact members of the former iGEM team Texas, Austin from 2014 who originally created the part BBa_K1416000. They sent us the ONBY-tRNA/synthetase pair in a backbone that carries a gentamycin resistance and is replicated with an ori that is not part of the same incompatibility group as the ori of pSB1C3.
+Fortunately, we were able to contact members of the former iGEM team Texas, Austin from 2014 who originally created the part BBa_K1416000. They sent us the ONBY-tRNA/synthetase pair in a backbone that carries a gentamicin resistance and is replicated with an ori that is not part of the same incompatibility group as the ori of pSB1C3.
 <center><img src="https://static.igem.org/mediawiki/2016/8/80/T--Aachen--ecoli_labbook_texas_plasmid.PNG" style="width:600px;"/><center>
@@ Line 1,815: / Line 1,816: @@
 As we were not able to detect the expression of the modified proteases via SDS gel, we proceeded by executing a skim milk assay on agar plates containing IPTG and the needed antibiotics. Therefore, we streaked the cells containing the modified expression systems on these plates and incubated at 30°C for three days.<br/>
-<center><img src="https://static.igem.org/mediawiki/2016/1/10/T--Aachen--labbook_ecoli_skim_milk_mutated.png" style="width:600px;"/></center>
+<center><img src="https://static.igem.org/mediawiki/2016/3/3f/T--Aachen--Skim_Milk_plate_all.png" style="width:600px;"/></center>
-<figcaption style="text-align:center; font-size: 15px; padding-left:2cm;padding-right:2cm; "><b>Figure 1: Skim milk plates assay.</b> Cells containing the empty backbone (1) in comparison to either cells producing the native protease (2), cells with the SDM 1-modified (3) and the SDM 3-modified expression system (4) after incubation for 3 days at 30°C.</figcaption>
+<figcaption style="text-align:center; font-size: 15px; padding-left:2cm;padding-right:2cm; "><b>Figure 1: Skim milk plates assay.</b> Cells producing the native protease (picture A-C, left) in comparison to either cells containing the empty backbone (picture A, right) or cells carrying the SDM 3-modified (picture B, right) and the SDM 1-modified expression system (picture C, right) after incubation for 3 days at 30°C.</figcaption>
 <br/>
 <p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;">
@@ Line 1,848: / Line 1,849: @@
 <b style="color:#005c04;">Day 1</b><br/><br/>
-To characterize O-(2-nitrobenzyl)-L-tyrosine (ONBY), we decided to test the photocleavage with the “Light Box” provided by the iGEM team Düsseldorf 2016 and to analyze it using gas chromatography-mass spectrometry (GC-MS). To achieve this, we dissolved 5mg of ONBY powder in 100µl pyridine and incubated at 37°C for 10 minutes.
+To characterize O-(2-nitrobenzyl)-L-tyrosine (ONBY), we decided to test the photocleavage with the light box provided by the iGEM team Düsseldorf 2016 and to analyze it, using gas chromatography-mass spectrometry (GC-MS). To achieve this, we dissolved 5mg of ONBY powder in 100µl pyridine and incubated at 37°C for 10 minutes.
 Then, the analysis was executed via GC-MS with the following conditions:
 <ol style=" list-style-type: disc; padding-left:1.5cm; padding-right:1.5cm; align-content: center" >
@@ Line 1,856: / Line 1,857: @@
 <p align="justify" style="padding-left:1.0cm; padding-right:1.0cm; font-size: 16px;">
-The sample was then exposed to UV light of intensity 14.8mW/cm<sup>2</sup> with different exposure time of 1, 3, 5 and 10 minutes using the Light Box and then analyzed using the same GC-MS method described above. The exposure resulted in photocleavage and produced 2-nitroso benzaldehyde with a molecular weight of 132.122 g/mol. Compounds with similar molecular weight have an elution time of 5.3 minutes.
+The sample was then exposed to UV light of intensity 14.8 mW/cm<sup>2</sup> with different exposure time of 1, 3, 5 and 10 minutes using the light box and then analyzed using the same GC-MS method described above. The exposure resulted in photocleavage, and produced 2-nitroso benzaldehyde which has a molecular weight of 132.122 g/mol. Compounds with similar molecular weight have an elution time of 5.3 minutes.
 <center><img src="https://static.igem.org/mediawiki/2016/1/16/T--Aachen--labbook_ecoli_GC_figure1.jpg" style="width:600px;"/></center>
@@ Line 1,864: / Line 1,865: @@
 <p align="justify" style="padding-left:1.0cm; padding-right:1.0cm; font-size: 16px;">
-The chromatogram of the analyzed samples shows the appearance of a peak at 5.22 minutes close to the expected elution time of 5.3 minutes. We observed that as the exposure time was increased from 1 minutes to 10 minutes (figure 1, graph C-F) the intensity of the peak also amplified indicating an enlarged amount of cleavage product. Also the absence of this peak in pyridine (blank) and the sample without exposure (figure 1, graph A and B), supports the absence of cleavage product. However, due to the unavailability of standard 2-nitroso benzaldehyde we could not quantify the amount of cleaved product produced on UV exposure. The spectrum of the cleaved product shows peaks at 51, 52, 73 and 79 m/z (figure 2) almost similar to the data available. [1]
+The chromatogram of the analyzed samples shows the appearance of a peak at 5.22 minutes close to the expected elution time of 5.3 minutes. We observed that, as the exposure time was incremented from 1 minutes to 10 minutes (figure 1, graph C-F), the intensity of the peak also amplified indicating an increase in the amount of cleavage product. Also the absence of this peak in pyridine (blank) and the sample without exposure (figure 1, graph A and B), supports the absence of cleavage product. However, due to the unavailability of standard 2-nitroso benzaldehyde, we could not quantify the amount of cleaved product produced on UV exposure. The spectrum of the cleaved product show peaks at 51, 52, 73 and 79 m/z (figure 2) which is almost similar to the data available. [1]
 <center><img src="https://static.igem.org/mediawiki/2016/9/9b/T--Aachen--labbook_ecoli_GC_figure2.jpg" style="width:600px;"/></center>
@@ Line 1,879: / Line 1,880: @@
 <figcaption style="text-align:center; font-size: 15px; padding-left:2cm;padding-right:2cm; "><b>Figure 3: Increase in area under curve for peak at 5.22 minutes.</b></figcaption><br/><br/>
 <p align="justify" style="padding-left:1.0cm; padding-right:1.0cm; font-size: 16px;">
-Also based on similar measurements we observed a decrease in area for the peak at 19.02 minutes, indicating the presence and decrease in the concentration of ONBY (figure 4).
+Also based on similar measurements, we observed a decrease in area for the peak at 19.02 minutes, indicating the presence and decrease in the concentration of ONBY (figure 4).
 <center><img src="https://static.igem.org/mediawiki/2016/0/09/T--Aachen--labbook_ecoli_GC_figure4.jpg" style="width:600px;"/></center>
@@ Line 1,886: / Line 1,887: @@
 <p align="justify" style="padding-left:1.0cm; padding-right:1.0cm; font-size: 16px;">
-As a conclusion we deduced that the amount of cleavage product rises as the exposure time is extended.<br/><br/>
+As a conclusion, we deduced that the amount of cleavage product increases as the exposure time is extended.<br/><br/>
 <b style="color:#005c04;">Day 2</b><br/><br/>
-We intended to use the results of the characerization of the photocleavage of ONBY to irradiate our samples of the S221X- and Y77X-mutated proteases that we obatined through cultivation of the SDM 2 and SDM 4-modified expression system in <i>E. coli </i> BL21. Furthermore, we planned to perform a skim milk assay with these samples before and after irradiation and then compare the clearance and thereby the degradation efficiency of the containing proteases. With these results we wanted to prove that due to the incorporation of DMNB-serine in the catalyic triade the protease would loose its proteolytic activity and would only re-gain it after irradiation and the resulting photocleavage. <br/> <br/>
+We intended to use the results of the ONBY photocleavage characterization to irradiate our samples S221X- and Y77X-mutated proteases which were obtained through cultivation of the SDM 2 and SDM 4-modified expression system in <i>E. coli </i> BL21. Furthermore, we planned to perform a skim milk assay with these samples before and after irradiation and then the degradation efficiencies of the proteases were compared by the extent of clearance. With these results we wanted to prove that due to the incorporation of DMNB-serine in the catalytic triade of the protease would lose its proteolytic activity and would only re-gain it after irradiation which would result into photocleavage. <br/> <br/>
 </p>
 </div>
@@ Line 1,899: / Line 1,900: @@
          <div class=" content_area structure">
              <div class="single_header_title">
-                 <h1 style="padding-left: 0.8cm;"><a name="synthetase"class="anchor">Synthetase - incorporating DMNBS in <i>E. coli</i></a></h1>
+                 <h1 style="padding-left: 0.8cm;"><a name="synthetase"class="anchor">Synthetase - Incorporating DMNBS in <i>E. coli</i> </a></h1>
              </div>
@@ Line 1,923: / Line 1,924: @@
 <img src="https://static.igem.org/mediawiki/2016/b/b7/T--Aachen--timeline_synthetase_v2_10.png" align="middle" style="position:relative;top: 0px; left: -520px; " id="synthetase4_1">
-<img src="https://static.igem.org/mediawiki/2016/4/45/T--Aachen--timeline_yeast_v2_6.png" align="top" style="position:relative;top: -0px; left: -520px; cursor:pointer" id="synthetase4">
+<img src="https://static.igem.org/mediawiki/2016/4/45/T--Aachen--timeline_yeast_v2_6.png" align="top" style="position:relative;top: 1px; left: -520px; cursor:pointer" id="synthetase4">
 <img src="https://static.igem.org/mediawiki/2016/7/7e/T--Aachen--timeline_synthetase_v2_18.png" align="middle" style="position:relative;top: -27px; left: -545px; ">
-<img src="https://static.igem.org/mediawiki/2016/1/16/T--Aachen--timeline_yeast_v2_5.png"  align="middle"  style="position:relative;top: -140px; left: 349px; " id="synthetase5_1" />
+<img src="https://static.igem.org/mediawiki/2016/1/16/T--Aachen--timeline_yeast_v2_5.png"  align="middle"  style="position:relative;top: -145px; left: 350px; " id="synthetase5_1" />
-<img src="https://static.igem.org/mediawiki/2016/4/45/T--Aachen--timeline_yeast_v2_6.png"  align="middle"  style="position:relative;top: -140px; left: 351px; cursor:pointer" id="synthetase5" />
+<img src="https://static.igem.org/mediawiki/2016/4/45/T--Aachen--timeline_yeast_v2_6.png"  align="middle"  style="position:relative;top: -145px; left: 351px; cursor:pointer" id="synthetase5" />
-<img src="https://static.igem.org/mediawiki/2016/d/d1/T--Aachen--timeline_synthetase_v2_19.png" align="top" style="position:relative;top: -167px; left: 321px; ">
+<img src="https://static.igem.org/mediawiki/2016/d/d1/T--Aachen--timeline_synthetase_v2_19.png" align="top" style="position:relative;top: -172px; left: 321px; ">
-<img src="https://static.igem.org/mediawiki/2016/1/16/T--Aachen--timeline_yeast_v2_5.png"  align="middle"  style="position:relative;top: -140px; left: 311px; " id="synthetase6_1" />
+<img src="https://static.igem.org/mediawiki/2016/1/16/T--Aachen--timeline_yeast_v2_5.png"  align="middle"  style="position:relative;top: -145px; left: 311px; " id="synthetase6_1" />
-<img src="https://static.igem.org/mediawiki/2016/4/45/T--Aachen--timeline_yeast_v2_6.png"  align="middle"  style="position:relative;top: -140px; left: 313px; cursor:pointer" id="synthetase6" />
+<img src="https://static.igem.org/mediawiki/2016/4/45/T--Aachen--timeline_yeast_v2_6.png"  align="middle"  style="position:relative;top: -145px; left: 313px; cursor:pointer" id="synthetase6" />
-<img src="https://static.igem.org/mediawiki/2016/0/09/T--Aachen--timeline_synthetase_v2_20.png" align="top" style="position:relative;top: -167px; left: 283px; ">
+<img src="https://static.igem.org/mediawiki/2016/0/09/T--Aachen--timeline_synthetase_v2_20.png" align="top" style="position:relative;top: -172px; left: 283px; ">
-<img src="https://static.igem.org/mediawiki/2016/1/16/T--Aachen--timeline_yeast_v2_5.png"  align="middle"  style="position:relative;top: -140px; left: 276px; " id="synthetase7_1" />
+<img src="https://static.igem.org/mediawiki/2016/1/16/T--Aachen--timeline_yeast_v2_5.png"  align="middle"  style="position:relative;top: -145px; left: 276px; " id="synthetase7_1" />
-<img src="https://static.igem.org/mediawiki/2016/4/45/T--Aachen--timeline_yeast_v2_6.png"  align="middle"  style="position:relative;top: -140px; left: 278px; cursor:pointer" id="synthetase7" />
+<img src="https://static.igem.org/mediawiki/2016/4/45/T--Aachen--timeline_yeast_v2_6.png"  align="middle"  style="position:relative;top: -145px; left: 278px; cursor:pointer" id="synthetase7" />
-<img src="https://static.igem.org/mediawiki/2016/1/13/T--Aachen--timeline_synthetase_v2_21.png" align="top" style="position:relative;top: -167px; left: 248px; ">
+<img src="https://static.igem.org/mediawiki/2016/1/13/T--Aachen--timeline_synthetase_v2_21.png" align="top" style="position:relative;top: -173px; left: 248px; ">
-<img src="https://static.igem.org/mediawiki/2016/1/16/T--Aachen--timeline_yeast_v2_5.png"  align="middle"  style="position:relative;top: -140px; left: 244px; " id="synthetase8_1" />
+<img src="https://static.igem.org/mediawiki/2016/1/16/T--Aachen--timeline_yeast_v2_5.png"  align="middle"  style="position:relative;top: -145px; left: 244px; " id="synthetase8_1" />
-<img src="https://static.igem.org/mediawiki/2016/6/65/T--Aachen--timeline_yeast_v2_4.png"  align="middle"  style="position:relative;top: -140px; left: 249px; cursor:pointer" id="synthetase8" />
+<img src="https://static.igem.org/mediawiki/2016/6/65/T--Aachen--timeline_yeast_v2_4.png"  align="middle"  style="position:relative;top: -145px; left: 249px; cursor:pointer" id="synthetase8" />
-<img src="https://static.igem.org/mediawiki/2016/6/6d/T--Aachen--timeline_synthetase_v2_24.png" align="top" style="position:relative;top: -205px; left: 183px; ">
+<img src="https://static.igem.org/mediawiki/2016/6/6d/T--Aachen--timeline_synthetase_v2_24.png" align="top" style="position:relative;top: -217px; left: 183px; ">
 <img src="https://static.igem.org/mediawiki/2016/b/b7/T--Aachen--timeline_synthetase_v2_11.png
-" align="top" style="position:relative;top: -51px; left: -219px; " id="synthetase9_1">
+" align="top" style="position:relative;top: -56px; left: -219px; " id="synthetase9_1">
-<img src="https://static.igem.org/mediawiki/2016/6/65/T--Aachen--timeline_yeast_v2_4.png" align="middle" style="position:relative;top: -49px; left: -217px; cursor:pointer" id="synthetase9">
+<img src="https://static.igem.org/mediawiki/2016/6/65/T--Aachen--timeline_yeast_v2_4.png" align="middle" style="position:relative;top: -50px; left: -217px; cursor:pointer" id="synthetase9">
-<img src="https://static.igem.org/mediawiki/2016/0/06/T--Aachen--timeline_synthetase_v2_23.png" align="middle" style="position:relative;top: -2px; left: -314px; " >
+<img src="https://static.igem.org/mediawiki/2016/0/06/T--Aachen--timeline_synthetase_v2_23.png" align="middle" style="position:relative;top: -4px; left: -314px; " >
-<img src="https://static.igem.org/mediawiki/2016/1/1c/T--Aachen--synthetase_new3.png" align="middle" style="position:relative;top: -145px; left: 447px; " id="synthetase10_1">
+<img src="https://static.igem.org/mediawiki/2016/1/1c/T--Aachen--synthetase_new3.png" align="middle" style="position:relative;top: -155px; left: 447px; " id="synthetase10_1">
-<img src="https://static.igem.org/mediawiki/2016/5/54/T--Aachen--synthetase_new4.png"  align="middle" style="position:relative;top: -190px; left: 440px; " id="synthetase10_2"/>
+<img src="https://static.igem.org/mediawiki/2016/5/54/T--Aachen--synthetase_new4.png"  align="middle" style="position:relative;top: -200px; left: 440px; " id="synthetase10_2"/>
-<img src="https://static.igem.org/mediawiki/2016/6/65/T--Aachen--timeline_yeast_v2_4.png" align="middle" style="position:relative;top: -235px; left: 445px; cursor:pointer" id="synthetase10">
+<img src="https://static.igem.org/mediawiki/2016/6/65/T--Aachen--timeline_yeast_v2_4.png" align="middle" style="position:relative;top: -245px; left: 445px; cursor:pointer" id="synthetase10">
-<img src="https://static.igem.org/mediawiki/2016/6/6e/T--Aachen--timeline_synthetase_v2_25.png" align="middle" style="position:relative;top: -272px; left: 397px; " >
+<img src="https://static.igem.org/mediawiki/2016/6/6e/T--Aachen--timeline_synthetase_v2_25.png" align="middle" style="position:relative;top: -282px; left: 397px; " >
-<img src="https://static.igem.org/mediawiki/2016/1/16/T--Aachen--timeline_yeast_v2_5.png" align="middle" style="position:relative;top: -235px; left: 388px; " id="synthetase11_1">
+<img src="https://static.igem.org/mediawiki/2016/1/16/T--Aachen--timeline_yeast_v2_5.png" align="middle" style="position:relative;top: -245px; left: 388px; " id="synthetase11_1">
-<img src="https://static.igem.org/mediawiki/2016/6/65/T--Aachen--timeline_yeast_v2_4.png" align="middle" style="position:relative;top: -235px; left: 390px; cursor:pointer" id="synthetase11">
+<img src="https://static.igem.org/mediawiki/2016/6/65/T--Aachen--timeline_yeast_v2_4.png" align="middle" style="position:relative;top: -245px; left: 390px; cursor:pointer" id="synthetase11">
-<img src="https://static.igem.org/mediawiki/2016/8/84/T--Aachen--timeline_synthetase_v2_26.png" align="middle" style="position:relative;top: -302px; left: 349px; " >
+<img src="https://static.igem.org/mediawiki/2016/8/84/T--Aachen--timeline_synthetase_v2_26.png" align="middle" style="position:relative;top: -312px; left: 349px; " >
 <acronym title="close" style="cursor:pointer; border-bottom: 0px">
 <i class="fa fa-times synthetaseclose" style=" position:relative;top: -15px; left: 324px;font-size: 20px; margin-top: -150px;"></i></acronym>
@@ Line 1,968: / Line 1,969: @@
 <br/>
 <p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;">
-</p>
+The development of a screening system, which was needed to test for the activity of a synthetase incorporating a ncAA, is a difficult and time consuming task. Therefore, we used a reporter plasmid, which was established and characterized by <a href="https://2014.igem.org/Team:Austin_Texas/kit"><u style="color:#0000EE;">iGEM Team Austin, Texas, 2014</u></a>. It offers the opportunity to approximate incorporation values based on fluorescence proteins.
+</br>
+The reporter plasmid codes for mRFP1 and sfGFP which are IPTG inducible. mRFP1 is linked to sfGFP by a sequence which includes the amber stop codon. mRFP1 is (if induced) expressed constitutively and if the orthogonal mutated synthetase is capable of recognizing the ncAA and loading it on the tRNA with the amber anticodon, is followed by sfGFP. Else, the expression stops at the amber stop codon in the linker.
 </div>
 <div class="circle2">
-<h2 style="border-bottom: 5px solid #005b04;padding-left: 1.0cm;">Definition of incubation conditions</h2>
+<h2 style="border-bottom: 5px solid #005b04;padding-left: 1.0cm;">Definition of Incubation Conditions</h2>
 <br/>
-<p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;"><b style="color:#005b04; ">Arrival and Preparation of Testkit with DNA from Texas</b><br/>
+<p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;"><b style="color:#005b04;"> Decision for host strain</b><br/>
-Recovery of plasmids in TRIS buffer pH 8.5, followed by transformation in BL21 DE3 gold, LB solid plates with Gentamycin 30 µg/ml.<br/><br/>
+An amberless <i>E. coli</i> strain has been developed which only expresses proteins with stop codons excluding the amber stop codon. For our purpose we chose not to work with this strain. In our working strain <i>E. coli</i> BL21 DE3 gold the release factor 1 competes with the tRNA loaded with the ncAA. Still enough proteins with the amber as a stop codon are expressed funtionally. Moreover, the affinity of the tRNA to the amber stop codon on the mRNA is high enough to incorporate the ncAA in any target protein.
-<b style="color:#005b04; ">Determining concentration of antibiotcs in LB</b><br/>
-The growth of <i>E. coli</i> cells transformed with plasmids wild type tyrosine -tRNA/synthetase and oNBY-tRNA/synthetase on LB solid as well as in LB liquid is not affected by concentrations of gentamycin up to 30 µg/ml, whereas a wild type BL21 DE3 gold is affected already at 5 µg/ml. Hence, appropriate concentration for gentamycin plates and cultures is 30 µg/ml. This observation is also valid for 50 µg/ml Kanamycin tested with transformed reporter plasmids in BL21 DE3 gold. <br/>
+<p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;"><b style="color:#005b04; ">Arrival and Preparation of Test Kit with DNA from Texas</b><br/>
-Furthermore the combination of the two antibiotics is evaluated. Since BL21 DE3 gold showed a proper growth rate in LB with 30 µg/ml gentamycin + 50 µg/ml Kanamycin when transformed with a reporter plasmid and a synthetase plasmid the assessed concentrations are kept.<br/><br/>
+After receiving the test kit the plasmids were recovered in TRIS buffer pH 8.5. The diluted DNA was then transformed in <i>E. coli </i> BL21 DE3 gold cells which were cultivated on LB solid plates. After 1 Day of growth the cells were prepared as overnight cultures. Following the incubation, plasmids were isolated according to protocol.
-<b style="color:#005b04; ">Determining concentration of atibiotics in M9 minimal medium</b><br/>
+<br/>
-Competent cells already containing the reporter plasmid pFRY are beeing transformed with the PCR product from Site Saturated Mutagenesis 3 onto M9 solid with different antibiotics concentration and afterwards picked in overnight cultures with the same antibiotics concentrations. A gel electrophoresis as well as a colony PCR is made to detect, if the concentration of both antibiotics is high enough to have an appropriate pressure on the cells, but is low enough, so that cultivation of cells is after all possible in minimal medium. The growth on microtiter plates is as well evaluated via plate reader.<br/>
+<br/>
-Gentamycin 5 µg/mg + Kanamycin 50 µg/ml is the only concentration where <i>E. coli</i> is growing and reliably keeps both plasmids. As after transformation on M9 solid with Gentamycin 5 µg/ml some wild type BL21 colonies grew, gentamycin concentration in M9 solid was increased: Transformation onto Gentymacin 10 µg/ml + Kanamycin 50 µg/ml  and subsequent  picking in liquid M9 cultures with Gentymacin 5 µg/ml + Kanamycin 50 µg/ml resulted in practically no growth of BL21 wild type but in appropriate growth rates of cells transformed with two plasmids.
+<b style="color:#005b04; ">Preparation of Chemical Competent Cells hosting the reporter plasmid pRXG</b><br/>
+The reporter plasmid pRXG was transformed onto LB plates. Subsequently, some colonies were picked for overnight cultures. Thereof cryo cultures were prepared. The plasmids were isolated and sent for sequencing.
+The cryo cultures were then used to inoculate precultures and prepare chemical competent cells according to the protocol.<br/>
+</br>
+<b style="color:#005b04; ">Determining Concentration of Antibiotics in LB</b><br/>
+The growth of <i>E. coli</i> cells transformed with plasmids containing wild type tyrosyl-tRNA/synthetase and oNBY-tRNA/synthetase on LB solid as well as in LB liquid is not affected by concentrations of gentamicin up to 30 µg/ml, whereas a wild type <i>E. coli</i> BL21 DE3 gold is affected already at 5 µg/ml. Hence, appropriate concentration for gentamicin plates and cultures is 30 µg/ml. This observation is also valid for 50 µg/ml kanamycin tested with transformed reporter plasmids in <i>E. coli </i> BL21 DE3 gold. <br/>
+Furthermore the combination of the two antibiotics is evaluated. Since the cells showed a proper growth rate in LB with 30 µg/ml gentamicin + 50 µg/ml kanamycin when transformed with a reporter plasmid and a synthetase plasmid the assessed concentrations are kept.<br/>
+<img src="https://static.igem.org/mediawiki/2016/d/dc/T--Aachen--Labbook-Gent_conc_plates.jpeg" style="width:900px"/>
+<figcaption style="text-align:center; font-size: 15px; padding-left:2cm;padding-right:2cm; "><b>Figure 1: antibiotics test </b>- growth on plates with gentamicin in concentrations: 30, 35, 40, 45, 50 µg/ml</figcaption><br/>
+<br/>
+<p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;">
+<b style="color:#005b04; ">Determining Concentration of Antibiotics in M9 Minimal Medium</b><br/>
+By cultivation of cells transformed with one of the two types of plasmids (antibiotic resistances: kanamycin/gentamicin) and incubating on plates with different antibiotics concentrations the correct working concentrations were found. After having tested the growth on plates we cultivated the cells in liquid medium with the same antibiotics concentrations to also check it under this conditions.
+For this determination we evaluated the growth on the plates and in the test tubes.
+To make sure the cells kept the plasmids we performed a colony PCR (plates) or plasmid isolation (liquid) followed by gel electrophoresis.(picture)
+With the found concentrations we performed the same experiment but with both plasmids and antibiotics at the same time to find a proper concentration combination of both antibiotics.
+It was high enough to have an appropriate pressure on the cells, but was low enough, so that cultivation was  possible in minimal medium.
+</br>
+The growth on microtiter plates was as well evaluated via plate reader.<br/>
+Our chosen concentration where <i>E. coli</i> is growing and reliably keeps both plasmids can be found in the following list.
 <li style=" list-style-type: none; padding-left : 1cm; padding-right:1cm; align-content: center"><span>
-Concentrations used in M9  solid medium with BL21 DE3 gold:</span>
+Concentrations used in M9  solid medium with <i>E. coli</i> BL21 DE3 gold:</span>
 <ol style=" list-style-type: disc; padding-left:0.1cm; padding-right:0.1cm; align-content: center" >
-<li style="padding-right: 0.3cm;"><span>Gentamycin 10 µg/ml</span></li>
+<li style="padding-right: 0.3cm;"><span>Gentamicin 10 µg/ml</span></li>
 <li style="padding-right: 0.3cm;"><span>Kanamycin 50 µg/ml</span></li>
 </ol>
@@ Line 1,993: / Line 2,018: @@
 <li style=" list-style-type: none; padding-left:1cm; padding-right:1cm; align-content: center"><span>
-Concentrations used in M9  liquid medium with BL21 DE3 gold:</span>
+Concentrations used in M9  liquid medium with <i>E. coli</i> BL21 DE3 gold:</span>
 <ol style=" list-style-type: disc; padding-left:0.1cm; padding-right:0.1cm; align-content: center" >
-<li style="padding-right: 0.3cm;"><span>Gentamycin 5 µg/ml and </span></li>
+<li style="padding-right: 0.3cm;"><span>Gentamicin 5 µg/ml and </span></li>
 <li style="padding-right: 0.3cm;"><span>Kanamycin 10 µg/ml</span></li>
 </ol>
 </li>
 <br/>
-<p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;"><b style="color:#005b04; ">Determining cultivation temperature</b><br/>
-All single and double transformed <i>E. coli</i> cells in LB liquid and solid show an appropriate growth rate at 37°C. Whereas evaluation of growth rates with M9 minimal medium gives better results in 30°C.
-<br/><br/>
-<b style="color:#005b04; ">Preparation of chemical competent cells</b><br/>
-A transformation of the reporter plasmid pRXG into BL21 DE3 gold onto LB solid with Gentamycin 30 µg/ml is made. Subsequently some colonies are picked for overnight culture. Thereof cryo cultures are prepared as well as the isolated plasmids are sent for sequencing. One cryo culture is used to inoculate several overnight cultures from which competent cells are prepared via TFB-method.<br/>
 <br/>
-<b style="color:#005b04; ">Results from testing transformation efficiency</b>
+<p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;">
+<b style="color:#005b04; ">Testing Transformation Efficiency</b>
 <br/>
-To get a maximum of colonies with transformation of the mutation library, the transformation method is tested as follows: Double transformation with two plasmids, i.e. pFRY and Y-RS, is generally lower in efficiency than single transformation. By a factor of ca. 1000 lower in efficiency to double transformation is double transformation with one plasmid and one PCR product. To have both plasmids in one cell, the best solution is transformation of a PCR product in competent cells which already contain the reporter plasmid pFRY. Colonies appear smaller in comparison to BL21, because they have two additional plasmids resulting in metabolic burden and hence a lower growth rate. Compared to double transformation, the number of cells is higher by a factor of 10. Own competent cells  already containing the reporter plasmid have only minimal lower transformation efficiency than BL21 DE3 gold, when transformed with a single plasmid.
+To get a maximum of colonies with transformation of the mutant library, the following tranformation methods were tested:
+</br>
+<p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;">
+<span style="color:#7fb983"> A)</span> co-transformation of both plasmids at the same time: reporter + tRNA/synthetase plasmid
+</br>
+<span style="color:#7fb983"> B)</span> transformation of chemical competent cells (already hosting the reporter plasmid) with tRNA/synthetase plasmid
+</br>
+</br>
+Conclusion: To have both plasmids in one cell, the best solution is the transformation of the tRNA/synthetase plasmid as PCR product (deriving from mutagenesis PCR) in competent cells which already contain the reporter plasmid pRXG. Colonies appear smaller in comparison to <i>E. coli</i> BL21, because they have two additional plasmids resulting in metabolic burden and hence a lower growth rate. Compared to co-transformation, the number of cells is higher by a factor of 10.
 <br/><br/>
-<b style="color:#005b04; ">Results from testing  various cultivation steps</b>
+<b style="color:#005b04; ">Testing Various Cultivation Steps</b>
 <br/>
 As transformation on LB solid with subsequent picking in M9 liquid resulted in almost no growth, proper cell growth is achieved by the following method:<br/>
@@ Line 2,041: / Line 2,070: @@
 <p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;">Cryo cultures are made from all intermediate steps.<br/>
 <br/>
-<b style="color:#005b04; ">DMNBS</b><br/>
+<b style="color:#005b04; ">Dissolving DMNB-serine (DMNBS)</b><br/>
-DMNBS is soluble in 50% DMSO at basic pH. A stock of 50mM is prepared and used with a final concentration in M9 at 2 mM resulting in a pH value within the medium solution of 7.55.<br/>
+DMNBS is soluble in 50% DMSO at basic pH. A stock of 50mM is prepared and used with a final concentration in M9 of 2 mM resulting in a pH value of 7.55.<br/>
 <br/>
-<b style="color:#005b04; ">Determining growth with DMNBS</b><br/>
+<b style="color:#005b04; ">Determining Growth with DMNBS</b><br/>
-When replicating from a microtiter plate with M9 minimal medium into another with M9 and addition of both antibiotics, 100 mM IPTG and 2 mM DMNBS it is shown that growth of cells is affected slightly resulting in an elongated growth phase. Cultures reach their maximum cell density after 42-48 h of growth.
+Cultivating <i>E. coli</i> BL21 DE3 gold containing two different plasmids shows lower growth rates when adding 100µM IPTG and 2mM DMNBS to M9 minimal medium, resulting in an overall growth time of 42-48h.
 </p>
 </p>
@@ Line 2,052: / Line 2,081: @@
 <div class="circle3">
-<h2 style="border-bottom: 5px solid #005b04;padding-left: 1.0cm;">Modelling of binding pocket of DMNBS-synthetase</h2>
+<h2 style="border-bottom: 5px solid #005b04;padding-left: 1.0cm;">Modelling of Binding Pocket of DMNBS-Synthetase</h2>
 <br/>
-<p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;">Extensive research on previously observed mutation spots of different kinds of evaluated synthetases for ncAA as well as on highly conserved amino acids is made. Upon comparison of the crystal structures of EcLeu-tRNA/RS with various mutated tRNA/synthetase pairs eventually the decision is made for mutating  wild type <i>Methanoococcus janaschii</i> tyrosyl tRNA/synthetase pair to a DMNBS specificity. Clashes of the synthetase backbone with DMNBS do not occur. Furthermore this pair had been reported to be orthogonal in <i>E. coli</i>. The mutation sites are determined with respect to chemical properties, space for photoprotection group and codon usage. The well working DMNBS-tRNA/synthetase pair derived from Leucyl Ec-tRNA/syntehtase pair is evaluated in order to align mutation spots.</p>
+<p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;">
+We did research on already published mutated synthetases and chose the wild type <i>Methanococcus jannaschii</i> tyrosyl tRNA/synthetase pair to mutate for DMNBS specificity. This pair has already been reported to be orthogonal in <i>E. coli</i> and was mutated for the use with other ncAAs.</br>
+By computational analysis and comparison to the <i>E. coli</i> leucyl tRNA/synthetase pair which has been changed to DMNBS affinity, amino acids in the binding pocket were identified. These needed to be mutated to achieve DMNBS specificity in the <i>Methanococcus jannaschii</i> tyrosyl tRNA/synthetase pair. We were lucky that the synthetase backbone was not affected by the size of the ncAA. The other mutation sites were determined with respect to chemical properties, space for the photoprotection group and codon usage of <i>E. coli</i>.</p>
+<p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;">
+<center><img src="https://static.igem.org/mediawiki/2016/2/2d/T--Aachen--Labbook-modelling_DMNBS.png" style="width:600px"></center>
+<figcaption  style="text-align: center; font-size:15px; position:relative;top: 10px; left: 10px; "><b>Figure 1: ncAA (DMNB-serine) in binding pocket of <i>Methanococcus jannaschii</i> tyrosyl synthetase</b></figcaption><br/>
+</p>
 </div>
@@ Line 2,063: / Line 2,100: @@
 <h2 style="border-bottom: 5px solid #005b04;padding-left: 1.0cm;">SDM Site Directed Mutagenesis</h2>
 <br/>
-<p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;">Tyrosine 32 is mutated to glycine in a site directed mutagenesis with a full gradient two step PCR due to it is known H-bonds with former ligand of the  tRNA/synthetase tyrosine. Elongation time is set to 50 sec/kbp.<br/>
+<p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;">Tyrosine at position 32 was mutated to glycine by site directed mutagenesis with a full gradient two step PCR. Elongation time was set to 50 sec/kbp.<br/>
-Gel electrophoresis shows a successful amplification at the expected length. Tubes are pooled, cleaned and transformed into <i>E. coli</i> BL21 DE3 gold. Sequencing results show in 4 out of 4 colonies the replacement through glycin. <br/>
-(picture Gel SDM)<br/><br/>
-Initially it was tried to saturate the remaining 5 mutation sites via a two step Omnichange protocol. It was shown, that, due to the given DNA sequence and the protocol recommendations, the design of one of the primers made the execution of the protocol nearly impossible. As a conseuqence we opted for repeated Single Site Saturation Mutagenesis to reach the goal.
+<table align="center" style="width:90%; border:2pt solid black;margin-left: auto; margin-right: auto;">
+<tr>
+<td rowspan="2" style="border:2pt solid black;background-color:#005C04;"></td>
+</tr>
+<tr >
+<th style="border:2pt solid black;background-color:#005C04;">temperature</th>
+<th style="border:2pt solid black;background-color:#005C04;">duration</th>
+<th style="border:2pt solid black;background-color:#005C04;">cycles</th>
+</tr>
+<tr>
+<th  scope="row" style="border:2pt solid black; background-color:white;">Initial denaturation</th>
+<td style="border:2pt solid black;">98°C</td>
+<td style="border:2pt solid black;">30s</td>
+<td style="border:2pt solid black;"></td>
+</tr>
+<tr>
+<th  scope="row" style="border:2pt solid black; background-color:white;">Denaturation</th>
+<td style="border:2pt solid black;">98°C</td>
+<td style="border:2pt solid black;">10s</td>
+<td  rowspan="3" style="border:2pt solid black; position:relative;top: 0px; left:0px">3 cycles</td>
+</tr>
+<tr>
+<th  scope="row" style="border:2pt solid black; background-color:white;">Annealing</th>
+<td style="border:2pt solid black;">Gradient from 61°C to 71°C</td>
+<td style="border:2pt solid black;">45s</td>
+</tr>
+<tr>
+<th  scope="row" style="border:2pt solid black; background-color:white;">Elongation</th>
+<td style="border:2pt solid black;">5 min</td>
+</tr>
+</table>
+<figcaption style="text-align:center; font-size: 15px; padding-left:2cm;padding-right:2cm; "><b>Figure 1: PCR program 1</b></figcaption>
+<table align="center" style="width:90%; border:2pt solid black;margin-left: auto; margin-right: auto;">
+<tr>
+<td rowspan="2" style="border:2pt solid black;background-color:#005C04;"></td>
+</tr>
+<tr >
+<th style="border:2pt solid black;background-color:#005C04;">temperature</th>
+<th style="border:2pt solid black;background-color:#005C04;">duration</th>
+<th style="border:2pt solid black;background-color:#005C04;">cycles</th>
+</tr>
+<tr>
+<th  scope="row" style="border:2pt solid black; background-color:white;">Initial denaturation</th>
+<td style="border:2pt solid black;">98°C</td>
+<td style="border:2pt solid black;">30s</td>
+<td style="border:2pt solid black;"></td>
+</tr>
+<tr>
+<th  scope="row" style="border:2pt solid black; background-color:white;">Denaturation</th>
+<td style="border:2pt solid black;">98°C</td>
+<td style="border:2pt solid black;">10s</td>
+<td  rowspan="3" style="border:2pt solid black; position:relative;top: 0px; left:0px">15 cycles</td>
+</tr>
+<tr>
+<th  scope="row" style="border:2pt solid black; background-color:white;">Annealing</th>
+<td style="border:2pt solid black;">Gradient from 61°C to 71°C</td>
+<td style="border:2pt solid black;">45s</td>
+</tr>
+<tr>
+<th  scope="row" style="border:2pt solid black; background-color:white;">Elongation</th>
+<td style="border:2pt solid black;">72°C</td>
+<td style="border:2pt solid black;">5 min</td>
+</tr>
+<tr>
+<th  scope="row" style="border:2pt solid black; background-color:white;">Final elongation</th>
+<td style="border:2pt solid black;">72°C</td>
+<td style="border:2pt solid black;">10min</td>
+<td style="border:2pt solid black;"></td>
+</tr>
+</table>
+<figcaption style="text-align:center; font-size: 15px; padding-left:2cm;padding-right:2cm; "><b>Figure 2: PCR program 2</b></figcaption><br/>
+<p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;">
+Gel electrophoresis of the PCR product showed a successful amplification at the expected length. <br/>
+<center><img src="https://static.igem.org/mediawiki/2016/0/0d/T--Aachen--SDM_afterdigest.jpg"></center>
+<figcaption style="text-align:center; font-size: 15px; padding-left:2cm;padding-right:2cm; "><b>Figure 3: Gel electrophoresis of Site Directed Mutagenesis showing a PCR product at the expected length at 5321 bp</b></figcaption>
+<p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;">
+</br>
+<b>0:</b> ladder
+</br>
+<b>1-11:</b> temperature gradient: 61-71°C
+</br>
+The tubes were pooled, cleaned and transformed into <i>E. coli</i> BL21 DE3 gold.
+The plates were used to prepare overnight cultures and on the following day, the plasmids were isolated.
+Sequencing results showed in 4 out of 4 colonies the successful replacement of the tyrosine by the glycine codon.
+<br/><br/>
 </p>
 </div>
@@ Line 2,072: / Line 2,200: @@
 <div class="circle5">
-<h2 style="border-bottom: 5px solid #005b04;padding-left: 1.0cm;">SSM1 Site Saturation Mutagenesis 1</h2>
+<h2 style="border-bottom: 5px solid #005b04;padding-left: 1.0cm;">SSM1 Site Saturated Mutagenesis 1</h2>
 <br/>
-<p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;">As the template for the first Site Saturation Mutagenesis the isolated plasmid from transformation  of SDM is used. A partially randomized codon optimized for the codon usage of <i>E. coli</i> within the primer is selected to establish a diversity of amino acids at the mutation site.  A full gradient two step PCR with an elongation time of 50 sec/kbp is performed on site L65 due to its location within the 2 Å radius of DMNBS. The subsequent gel electrophoresis showed the PCR product at expected length. <br/>
+<p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;">
-(picture Gel SSM1)<br/><br/>
+The isolated plasmid from SDM (Tyr32Gly) was used as template for further site saturated mutagenesis. A full gradient two step PCR with an elongation time of 50 sec/kbp was performed on site L65 due to its location within the 2 Å radius of DMNBS. The subsequent gel electrophoresis showed the PCR product at the expected length. <br/>
-Tubes are pooled and cleaned and the product is transformed into <i>E. coli</i> BL21 DE3 gold. Sequencing of 4 colonies shows in all 4 samples the successful mutation at the SDM1 site to various amino acids as well as the selected glycin codon at position 32.
+<center><img src="https://static.igem.org/mediawiki/2016/a/a0/T--Aachen--SSM1.png"></center>
+<figcaption style="text-align:center; font-size: 15px; padding-left:2cm;padding-right:2cm; "><b>Figure 1: Gel electrophoresis of Site Saturated Mutagenesis 1 showing a PCR product at the expected length of 5321 bp</b></figcaption>
+<br/><br/>
+<p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;">The tubes were pooled and cleaned and the product was transformed into <i>E. coli</i> BL21 DE3 gold. The sequencing of 4 colonies showed in all 4 samples the successful mutation at the SSM1 site to various amino acids as well as the glycine codon mutation at position 32.
 </p>
 </div>
@@ Line 2,082: / Line 2,213: @@
 <div class="circle6">
-<h2 style="border-bottom: 5px solid #005b04;padding-left: 1.0cm;">SSM2 Site Saturation Mutagenesis 2</h2>
+<h2 style="border-bottom: 5px solid #005b04;padding-left: 1.0cm;">SSM2 Site Saturated Mutagenesis 2</h2>
 <br/>
-<p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;">With the purpose of performing Site Saturation muatagenesis the colonies of SSM1 are washed off the transformation plates. The isolated plasmid is used as template for SSM2 at mutation site D158 and I159. The first site is to be mutated due to known H-bonds of the tRNA/synthetase complex with the former ligand tyrosine. Second site has a sidechain which is located within the 2 Å radius of DMNBS. Primer contain two partially randomized codons with one base which is left to be unchanged in the middle. A full gradient, two step PCR is performed with an elongation time of 50 sec/kbp. Subsequent gel electrophoresis shows a PCR product at the expected length. Tubes are pooled and product is isolated and subsequently transformed into <i>E. coli</i> BL21 DE3 gold. 4 out of 4 colonies are sequencend, where all previous mutation sites showed a glycine codon in SDM position as well as different mutations in various combinations at the three SSM sites.<br/>
+<p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;">With the purpose of performing Site Saturated Mutagenesis the colonies of SSM1 were washed off the transformation plates. The isolated plasmid was used as template for SSM2 (mutation sites D158 and I159). The first site was to be mutated due to known H-bonds of the tRNA/synthetase complex with the former ligand tyrosine. Second site had a sidechain, which was located within the 2 Å radius of DMNBS. The primers contain two partially randomized codons. A full gradient two step PCR was performed with an elongation time of 50 sec/kbp. Subsequent gel electrophoresis showed a PCR product at the expected length. The tubes were pooled and the product was isolated and subsequently transformed into <i>E. coli</i> BL21 DE3 gold. 4 out of 4 colonies were sequenced and the results still showed a glycine codon in SDM position as well as different mutations in various combinations at the three SSM sites.<br/>
+<center><img src=" https://static.igem.org/mediawiki/2016/5/5e/T--Aachen--SSM2.png "></center>
+<figcaption style="text-align:center; font-size: 15px; padding-left:2cm;padding-right:2cm; "><b>Figure 1: Gel electrophoresis of Site Saturated Mutagenesis 2 showing a PCR product at the expected length at 5321 bp </b></figcaption>
-(Picture Gel SSM2)
 </p>
 </div>
 <div class="circle7">
-<h2 style="border-bottom: 5px solid #005b04;padding-left: 1.0cm;">SSM 3: Site Saturated Mutagenesis 3</h2>
+<h2 style="border-bottom: 5px solid #005b04;padding-left: 1.0cm;">SSM3 Site Saturated Mutagenesis 3</h2>
 <br/>
-<p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;">Prior to washing the colonies off the transformation plates it is calculated if the transformation yielded as many colonies as theoretical variants up to SSM2. As counted colonies are twice as much as theoretical variants, colonies are washed off the transformation plates from SSM2. Plasmids are isolated and used as template for Site Saturation Mutagenesis 3. A full gradient two step PCR is performed with 50 sec/kbp elongation time. Gel electrophoresis is showing the PCR product to be at the expected length.<br/>
+<p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;">Colonies were washed off the transformation plates from SSM2. Plasmids were isolated and used as template for Site Saturation Mutagenesis 3. A full gradient two step PCR is performed with 50 sec/kbp elongation time. Gel electrophoresis showed the PCR product to be at the expected length.<br/>
-(Picture Gel SSM3)
+<center><img src="https://static.igem.org/mediawiki/2016/f/f9/T--Aachen--SSM3_1.png"></center>
+<figcaption style="text-align:center; font-size: 15px; padding-left:2cm;padding-right:2cm; "><b>Figure 1: Gel electrophoresis of Site Saturated Mutagenesis 3 showing a PCR product at the expected length at 5321 bp</b></figcaption>
 </p>
 </div>
 <div class="circle8">
-<h2 style="border-bottom: 5px solid #005b04;padding-left: 1.0cm;">Mutation Library</h2>
+<h2 style="border-bottom: 5px solid #005b04;padding-left: 1.0cm;">Mutant Library</h2>
+<br/>
+<p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;">For purposes of sequencing  12 transformations of the mutation library into <i>E. coli</i> BL21 DE3 gold were made and all results showed different codons in various combinations at all mutation sites, respectively a glycine at position 32. That means, all of our mutagenesis PCRs worked.<br/>
+The samples were pooled and the cleaned up PCR product was transformed into the competent cells already containing the reporter plasmid. They were streaked on M9 plates with the assessed concentrations of antibiotics for selection. After two days of incubation appropriate colonies were picked into microtiter plates containing M9 liquid Medium and respective antibiotics. Thus over 8000 clones were collected.
+The microtiterplates were incubated and used for inoculation of a second microtiter plate. A final inoculation into black microtiter plates with transparent bottom for screening followed this preculture. Induction with 100 µM IPTG as well as supplementation of 2 mM DMNBS was carried out at the beginning of this final cultivation (see results). <br/><br/>
+ <center><img src="https://static.igem.org/mediawiki/2016/4/4e/T--Aachen--sequencingSSM3.jpg"></center>
+<figcaption style="text-align:center; font-size: 15px; padding-left:2cm;padding-right:2cm; "><b>Figure 1: Sequencing results showing various mutations in saturated mutation spots with different combinations of codons. Aligned with Geneious 9.0.5.</b></figcaption>
 <br/>
-<p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;">For purposes of sequencing  12 transformations of the mutation library into BL21 DE3 gold are made and all sample results show different codons in various combinations at all mutation sites, respectively a glycine at position 32.<br/>
-As the mutation steps are now finished the pooled and cleaned up PCR product is transformed into the competent cells containing already the reporter plasmid, and is streaked on M9 solid with the assessed concentration of antibiotics for selection. After two days of incubation appropriate colonies are picked into microtiter plates containing M9 liquid and respective antibiotics. Thus over 8000 clones are collected. Following the previous assessment, an intermediate inoculation step was made and subsequently a final inoculation into black microtiter plates with transparent bottom. Induction with 100 µM IPTG as well as supplementation of 2 mM DMNBS was carried out at the beginning of the cultivation (see results). <br/><br/>
-(Picture of diversity of library, screenshot Geneious) .<br/>
 </p>
@@ Line 2,113: / Line 2,251: @@
 <div class="circle9">
 <h2 style="border-bottom: 5px solid #005b04;padding-left: 1.0cm;">
-Determine measurement conditions and parameter
+Determine measurement conditions and parameters
 </h2>
 <br/>
 <p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;">
-</p>
+Excitation and emission spectra of mRFP1 and sfGFP were obtained from fluorescence scan measurements (figure 1, figure 2). To get green and red fluorescence signals <i>E. coli</i> BL21 DE3 gold was transformed with the reporter plasmid pRXG and synthetase plasmid (wild type tyrosyl-tRNA/synthetase pair). The tRNA/synthetase pair coded by this plasmid (YRS) is the natural synthetase for incorporation of tyrosine, whereas the anticodon of the tRNA is mutated to recognize the amber stop codon. As a result, the linker downstream of mRFP1 is synthesized, harbouring tyrosine at the amber codon site. Following the linker, sfGFP is also expressed an its fluorescence signal is used to determine the correct wavelength for screening.</p>
-</div>
+<table style="border-collapse:separate;border:0px;border-spacing:20px;margin-top:0px;width: 920px;table-layout:fixed;">
+<tr>
+<td style="border:0pt;">
+<img src="https://static.igem.org/mediawiki/2016/e/e3/T--Aachen--mRFP1_scan.png" style="position:relative;top: -30px;left:-10px;width:400px;"/>
+<align="justify" figcaption style="font-size: 14px; position:relative;top: 0px; left:50px;"><b>Figure 1:  normalized fluorescence spectrum of mRFP1</b> - dotted line representing excitation and continuous line representing emission</figcaption>
+</td>
+<td style="border:0pt;">
+<img src="https://static.igem.org/mediawiki/2016/f/f4/T--Aachen--sfGFP_scan.png" style="position:relative;top: -2px;left:-40px;width:430px"/>
+<align="justify" figcaption style="font-size: 14px; position:relative;top:31px; left:10px; right:50px;"><b>Figure 2:  normalized fluorescence spectrum of sfGFP</b> - signal for successful amino acid incorporation by tRNA/synthetase pair via amber supression with dotted line representing excitation and continuous line representing emission</figcaption>
+</td>
+</tr>
+</table>
+<p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;">
+</br>
+For screening the following wavelength settings were used:
+</br></br>
+<b>OD:</b> 600 nm
+</br></br>
+<span style="color:#7FB983"><b>sfGFP:</span></b>
+</br>
+excitation: 480 nm
+</br>
+emission: 508 nm
+</br></br>
+<span style="color:#B42929"><b>mRFP1:</span></b>
+</br>
+excitation: 584 nm
+</br>
+emission: 605 nm
+</br>
+</div>
 <div class="circle10">
@@ Line 2,126: / Line 2,296: @@
 <br/>
 <p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;">
+As a prescreening setup an endpoint detection of OD and fluorescent intensities with a plate reader was chosen. Excitation and emission spectra of mRFP1 and sfGFP were obtained from a previously conducted measurement. <br/>
+<p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;">Thus a preselection of DMNBS tRNA/synthetase mutants was determined. A rescreening of mutants with promising effiency and fidelity was performed, to which an additional online measurement was made to obtain scattered light values as well as fluorescence intensities over time. This was carried out by an online measurement screening platform.
 </p>
 </div>
@@ Line 2,133: / Line 2,306: @@
 <h2 style="border-bottom: 5px solid #005b04;padding-left: 1.0cm;">Analysis
 </h2>
+<br/>
+<p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;">The DMNBS synthetase variants were evaluated by normalizing GFP fluorescence levels to the wild type tyrosyl synthetase and comparing the mutants to each other. Thus incorporation efficiency and fidelity values were obtained.
+<br/><br/>
+<center><img src="https://static.igem.org/mediawiki/parts/f/fd/T--Aachen--DMNBS-graph-efficiency.png" style="width:500px"></center>
+<figcaption style="text-align:center; font-size: 15px; padding-left:2cm;padding-right:2cm; "><b>Figure 1: Efficiency (dark green) and fidelity (light green) of various DMNBS mutants normalized to wild type Mj tyrosyl synthetase</b></figcaption>
 <br/>
 <p align="justify" style="padding-left: 1.0cm; padding-right: 1.0cm; font-size:16px;">
+These variants were sent for sequencing to obtain and discuss properties of amino acids which occur at the mutation spots.
+See <a href="http://parts.igem.org/Part:BBa_K1416003"><span style="color:#0000EE;">this link</span></a> for results.
 </p>
 </div>

Difference between revisions of "Team:Aachen/Notebook"

Latest revision as of 11:01, 4 December 2016

Lab Book

Photocaging - Targeting Serine in Saccharomyces cerevisiae

Expression of Subtilisin E

Determination of Parameters

Cloning

Test Expression

SDM Ser to UAG

Test Expression

Expression of Synthetase

Determination of Parameters

Check Genes

Test Expression

Co-transformation

Test Expression

Test Photocleavage and Activity

Photocaging - Targeting Tyrosine in Escherichia coli

Expression of subtilisin E in E. coli

Building the expression system

Testing the Expression

Testing the folding and activity

Mutating the expression system

Site-directed mutagenesis

Testing the expresion

Testing the folding and activity

Photoclevage

Irradiation

Synthetase - Incorporating DMNBS in E. coli

Research on screening system. Decision to work with kit from iGEM Team Austin, Texas 2014

Definition of Incubation Conditions

Modelling of Binding Pocket of DMNBS-Synthetase

SDM Site Directed Mutagenesis

SSM1 Site Saturated Mutagenesis 1

SSM2 Site Saturated Mutagenesis 2

SSM3 Site Saturated Mutagenesis 3

Mutant Library

Determine measurement conditions and parameters

Screening

Analysis